<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1368835</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1368835</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention</article-title>
<alt-title alt-title-type="left-running-head">Ding et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1368835">10.3389/fphar.2024.1368835</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Ding</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Song</surname>
<given-names>Yuanming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2673952/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zeng</surname>
<given-names>Cheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1980980/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Center for Drug Research and Development</institution>, <institution>Guangdong Pharmaceutical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Zhuhai People&#x2019;s Hospital</institution>, <institution>Zhuhai Clinical Medical College of Jinan University</institution>, <addr-line>Zhuhai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Key Specialty of Clinical Pharmacy</institution>, <institution>The First Affiliated Hospital of Guangdong Pharmaceutical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Guangdong Key Laboratory of Pharmaceutical Bioactive Substances</institution>, <institution>Guangdong Pharmaceutical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1028636/overview">Yusof Kamisah</ext-link>, Faculty of Medicine Universiti Kebangaan Malaysia, Malaysia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/512592/overview">Wei Sun</ext-link>, University of Pittsburgh Medical Center, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1216204/overview">Dezhao Lu</ext-link>, Zhejiang Chinese Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Cheng Zeng, <email>zengcheng@gdpu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1368835</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Ding, Song, Yang and Zeng.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Ding, Song, Yang and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>NOD-like receptor protein 3 (NLRP3) inflammasome is an intracellular sensing protein complex that possesses NACHT, leucine-rich repeat, and pyrin domain, playing a crucial role in innate immunity. Activation of the NLRP3 inflammasome leads to the production of pro-inflammatory cellular contents, such as interleukin (IL)-1&#x3b2; and IL-18, and induction of inflammatory cell death known as pyroptosis, thereby amplifying or sustaining inflammation. While a balanced inflammatory response is beneficial for resolving damage and promoting tissue healing, excessive activation of the NLRP3 inflammasome and pyroptosis can have harmful effects. The involvement of the NLRP3 inflammasome has been observed in various cardiovascular diseases (CVD). Indeed, the NLRP3 inflammasome and its associated pyroptosis are closely linked to key cardiovascular risk factors including hyperlipidemia, diabetes, hypertension, obesity, and hyperhomocysteinemia. Exercise compared with medicine is a highly effective measure for both preventing and treating CVD. Interestingly, emerging evidence suggests that exercise improves CVD and inhibits the activity of NLRP3 inflammasome and pyroptosis. In this review, the activation mechanisms of the NLRP3 inflammasome and its pathogenic role in CVD are critically discussed. Importantly, the purpose is to emphasize the crucial role of exercise in managing CVD by suppressing NLRP3 inflammasome activity and proposes it as the foundation for developing novel treatment strategies.</p>
</abstract>
<kwd-group>
<kwd>cardiovascular disease</kwd>
<kwd>exercise</kwd>
<kwd>pyroptosis</kwd>
<kwd>NLRP3 inflammasome</kwd>
<kwd>intervation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cardiovascular and Smooth Muscle Pharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Cardiovascular diseases (CVD) remain a prevalent global health concern, causing a significant burden of illness and mortality, with approximately one-third of all deaths attributed to this condition (<xref ref-type="bibr" rid="B79">Mensah et al., 2019</xref>). The common symptoms of CVD include chest pain, shortness of breath, irregular heartbeat, fatigue, and decreased physical stamina (<xref ref-type="bibr" rid="B127">Tutor et al., 2023</xref>; <xref ref-type="bibr" rid="B141">Wong and Sattar, 2023</xref>). CVD encompass various disorders that affect the heart and blood vessels, including atherosclerosis (AS), obesity, diabetes, hyperhomocysteinemia (HHcy), myocardial infarction (MI), hypertension, heart failure (HF), and diabetic cardiomyopathy (DCM) (<xref ref-type="bibr" rid="B50">Konishi et al., 2022</xref>; <xref ref-type="bibr" rid="B35">Haidar and Horwich, 2023</xref>). The conventional risk factors that are widely recognized for CVD, such as hypertension, hypercholesteremia, diabetes mellitus, and cigarette smoking, remain acknowledged as the main factors responsible for the development and advancement of this condition (<xref ref-type="bibr" rid="B2">Alten et al., 2020</xref>).</p>
<p>NOD-like receptor protein 3 (NLRP3) inflammasome is a molecular platform that triggers caspase-1 and facilitates the secretion of interleukin (IL)-1&#x3b2; and IL-18 in response to cellular infection or stress (<xref ref-type="bibr" rid="B129">Valenzuela et al., 2023</xref>). This activation results in the cleavage of gasdermin D (GSDMD) by caspase-1, generating an N-terminal GSDMD fragment (<xref ref-type="bibr" rid="B129">Valenzuela et al., 2023</xref>). This fragment induces the formation of membrane pores and triggers inflammatory cell death, namely pyroptosis (<xref ref-type="bibr" rid="B129">Valenzuela et al., 2023</xref>). The involvement of NLRP3 inflammasome and pyroptosis has been established in cardiovascular risk factors such as hyperlipidemia, diabetes, hypertension, obesity, and HHcy (<xref ref-type="bibr" rid="B2">Alten et al., 2020</xref>). Targeting NLRP3 inflammasome activation and pyroptosis holds great potential for therapeutic interventions against CVD.</p>
<p>Extensive research has demonstrated that exercise plays a crucial role in weight management (<xref ref-type="bibr" rid="B84">Murray et al., 2023</xref>), blood pressure (BP) reduction (<xref ref-type="bibr" rid="B126">Tucker et al., 2022</xref>), blood sugar (<xref ref-type="bibr" rid="B46">Kar et al., 2019</xref>) and lipid regulation (<xref ref-type="bibr" rid="B54">Lee et al., 2020</xref>), consequently lowering the risk of CVD (<xref ref-type="bibr" rid="B59">Li et al., 2023</xref>). Moreover, moderate exercise improves cardiovascular system function and structure, strengthens the heart muscle, enhances cardio-pulmonary function, promotes blood circulation, and increases the heart&#x2019;s tolerance and overall health (<xref ref-type="bibr" rid="B2">Alten et al., 2020</xref>). Furthermore, exercise exhibits a clear anti-inflammatory effect (<xref ref-type="bibr" rid="B54">Lee et al., 2020</xref>). It is widely acknowledged that exercise can effectively reduce chronic inflammation by inhibiting the expression of inflammatory factors while increasing the release of anti-inflammatory cytokines (<xref ref-type="bibr" rid="B54">Lee et al., 2020</xref>). Previous studies have indicated that exercise can decrease the activation of the NLRP3 inflammasome to substantially inhibit IL-1&#x3b2;, and IL-18 release (<xref ref-type="bibr" rid="B59">Li et al., 2023</xref>; <xref ref-type="bibr" rid="B64">Liu et al., 2023</xref>). This review mainly focuses on how exercise can improve CVD by influencing NLRP3 inflammasome or pyroptosis. Additionally, this review will investigate exercise as a therapeutic strategy via NLRP3 inflammasome for managing CVD and address the research questions that need to be explored in the future.1.</p>
</sec>
<sec id="s2">
<title>2 Overview of NLRP3 inflammasome</title>
<p>Inflammasomes are crucial components of the immune system that play a major role in initiating inflammatory responses (<xref ref-type="bibr" rid="B19">Chang, 2023</xref>). They are composed of sensor proteins known as pattern recognition receptors that oligomerize and form a platform for the activation of caspase-1 in response to damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs) (<xref ref-type="bibr" rid="B19">Chang, 2023</xref>). The nucleotide-binding domain-like receptor (NLR) family all share a central nucleotide-binding domain, and most members have a C-terminal leucine-rich repeat (LRR) domain and a variable N-terminal domain (<xref ref-type="bibr" rid="B120">Swanson et al., 2019</xref>). While certain members such as NLRP1, NLRP3, and NLRC4 are recognized as NLRs capable of forming inflammasomes, others like NLRP6 and NLRP12 are considered potential inflammasome sensors (<xref ref-type="bibr" rid="B120">Swanson et al., 2019</xref>). The NLRP3 inflammasome, in particular, is essential for the host&#x2019;s immune defense against various bacterial, fungal, and viral infections (<xref ref-type="bibr" rid="B32">Dilucca et al., 2021</xref>). However, when dysregulated, it has been implicated in the development of several inflammatory disorders, including CVD (<xref ref-type="bibr" rid="B93">Paerewijck and Lamkanfi, 2022</xref>).</p>
<p>The NLRP3 inflammasome is composed of several key components. The NLR protein in the NLRP3 inflammasome contains a conserved nucleotide-binding and oligomerization domain, C-terminal LRRs, and a pyrin domain (PYD) that facilitates multimerization (<xref ref-type="bibr" rid="B144">Xi et al., 2024</xref>). Upon activation of the NLRP3 inflammasome, the NLRs oligomerize through their nucleotide-binding and oligomerization domains (<xref ref-type="bibr" rid="B34">Fu and Wu, 2023</xref>). This leads to the recruitment of the adaptor protein apoptosis-associated speck-like protein (ASC) through PYD-PYD interactions (<xref ref-type="bibr" rid="B34">Fu and Wu, 2023</xref>). ASC then forms large speck-like structures and recruits pro-caspase-1 through caspase recruitment domain (CARD)-CARD interactions. Pro-caspase-1 undergoes autocatalytic cleavage, resulting in the formation of active caspase-1 p10/p20 tetramers (<xref ref-type="bibr" rid="B103">Ruan, 2019</xref>). These active caspase-1 tetramers mediate the maturation and secretion of IL-1&#x3b2; and IL-18 (<xref ref-type="bibr" rid="B103">Ruan, 2019</xref>; <xref ref-type="bibr" rid="B34">Fu and Wu, 2023</xref>). Additionally, caspase-1 can cleave GSDMD to generate GSDMD n-terminal (NT). GSDMD-NT forms plasma membrane pores, leading to the induction of pyroptosis (<xref ref-type="bibr" rid="B52">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="B90">Nie et al., 2021</xref>). The canonical activation of inflammasomes is proposed to occur in two steps: priming and assembly (<xref ref-type="bibr" rid="B10">Bockstiegel et al., 2023</xref>). Priming involves the initial activation of toll-like receptors by agonists such as lipopolysaccharide (LPS) (<xref ref-type="bibr" rid="B34">Fu and Wu, 2023</xref>). This trigger signaling cascades, primarily through the nuclear factor-&#x3ba;B (NF-&#x3ba;B) pathway, which leads to the transcriptional upregulation of pro-inflammatory mediators like pro-IL-1&#x3b2;. Following priming, the activated inflammasome assembles in response to various PAMPs or DAMPs (<xref ref-type="bibr" rid="B34">Fu and Wu, 2023</xref>; <xref ref-type="bibr" rid="B51">Krantz et al., 2023</xref>). This assembly forms a large molecular platform that activates inflammatory caspases and processes pro-IL-1&#x3b2; (<xref ref-type="bibr" rid="B43">Huang et al., 2023</xref>). The activation of NLRP3 inflammasome requires &#x201c;priming&#x201d; with TLR agonists to initiate signaling cascades (primarily nuclear factor-&#x3ba;B (NF-&#x3ba;B)-dependent pathway) that ultimately promote a transcriptional response to upregulate pro-inflammatory mediators (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Caspase-1-dependent canonical pyroptotic cell death induced by NLRP3 inflammasome activation. The assembly of the NLRP3 inflammasome involves NLRP3 oligomerization and ASC recruitment, triggering the autocleavage of pro-caspase-1. This autocleavage leads to the activation of caspase-1, which converts inactive pro-IL-1&#x3b2; and pro-IL-18 into their bioactive and secreted forms, namely IL-1&#x3b2; and IL-18. Additionally, active caspase-1 cleaves GSDMD, generating GSDMD-NT, which forms pores on the plasma membrane, inducing pyroptosis. Various models have been proposed to explain the assembly of the NLRP3 inflammasome. 1): Extracellular ATP can activate the NLRP3 inflammasome through different mechanisms. This includes the activation of the P2X7 receptor leading to the opening of the pannexin-1 pore, allowing the entry of extracellular factors that directly interact with NLRP3. Alternatively, NLRP3 can sense either the efflux of K&#x2b; or the loss of membrane integrity. 2): Crystalline or particulate agonists can be phagocytosed, resulting in the release of lysosomal cathepsins B and L, which are detected by the NLRP3 inflammasome. 3): NLRP3 agonists such as DAMPs and PAMPs can trigger the production of ROS, which activates the NLRP3 inflammasome. It is important to note that these models are not mutually exclusive but rather interact with each other. 4): The activation of the NLRP3 inflammasome also requires &#x201c;priming&#x201d; with TLR agonists, such as LPS.. (ASC: apoptosis-associated speck-like protein; TLRs: toll-like receptors; DAMPs: damage-associated molecular patterns; GSDMD: gasdermin D; NT: n-terminal; HSP: heat shock proteins; HMGB-1: high mobility group box-1; IL: interleukin; NLRP3: NOD-like receptor protein 3; NF-&#x3ba;B: nuclear factor-&#x3ba;B; PAMPs: pathogen-associated molecular patterns; P2X7: purinergic receptor P2X, ligand-gated ion channel 7; ROS: reactive oxygen species).</p>
</caption>
<graphic xlink:href="fphar-15-1368835-g001.tif"/>
</fig>
<p>K<sup>&#x2b;</sup> efflux is recognized as a crucial upstream signal for NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B164">Zhou et al., 2020</xref>). Activation of NLRP3 also requires the mobilization of Ca<sup>2&#x2b;</sup> (<xref ref-type="bibr" rid="B31">Diaz-Del-Olmo et al., 2021</xref>). Mobilization of Ca<sup>2&#x2b;</sup> occurs when extracellular Ca<sup>2&#x2b;</sup> moves across channels in the plasma membrane and the Ca<sup>2&#x2b;</sup> stored in the endoplasmic reticulum is released into the cytoplasm, which can induce NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B139">Watanabe et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Diaz-Del-Olmo et al., 2021</xref>). In addition, Cl<sup>&#x2212;</sup> was implicated in NLRP3 activation. Cl<sup>&#x2212;</sup> channel blockers and elevated levels of extracellular Cl<sup>&#x2212;</sup> can inhibit, whereas reduced levels of Cl<sup>&#x2212;</sup> can enhance, the activation of NLRP3 (<xref ref-type="bibr" rid="B164">Zhou et al., 2020</xref>). Cl<sup>&#x2212;</sup> efflux may be downstream of K<sup>&#x2b;</sup> efflux and affects ASC polymerization, whereas K<sup>&#x2b;</sup> efflux promotes NLRP3 oligomerization (Zhou et al., 2024).</p>
<p>In addition to the ion channels mentioned earlier that can activate the NLRP3 inflammasome, organelle dysfunction can also trigger inflammasome activation (<xref ref-type="bibr" rid="B82">Movahedpour et al., 2023</xref>). In a study, sterile lysosomal rupture caused by L-leucyl-L-leucine methyl ester is sufficient to trigger NLRP3 inflammasome activation, whereas suppression of phagosomal acidification or cathepsin B blocks NLRP3 activation (<xref ref-type="bibr" rid="B82">Movahedpour et al., 2023</xref>). Mitochondrial dysfunction contributes to the activation of the NLRP3 inflammasome (<xref ref-type="bibr" rid="B48">Kodi et al., 2024</xref>). When damaged organelles accumulate due to deficiencies in autophagic proteins, dysfunctional mitochondria release mitochondrial DNA, leading to NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B48">Kodi et al., 2024</xref>). Additionally, mitochondrial ROS (mtROS) can initiate NLRP3 activation (<xref ref-type="bibr" rid="B48">Kodi et al., 2024</xref>). Inhibiting autophagy or mitophagy results in the buildup of mitochondrial ROS and subsequent NLRP3 activation (<xref ref-type="bibr" rid="B22">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="B58">Lewisluj&#xe1;n et al., 2022</xref>; <xref ref-type="bibr" rid="B157">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="B66">Lu et al., 2023</xref>).</p>
<p>Post-transcriptional modifications of the NLRP3 protein occur in unstimulated cells and during priming and activation to modulate its activation and function (<xref ref-type="bibr" rid="B120">Swanson et al., 2019</xref>). In peritoneal macrophages, tripartite motif 31 ubiquitylates NLRP3, targeting it for proteasomal degradation (<xref ref-type="bibr" rid="B18">Chan and Schroder, 2020</xref>). The E3 ubiquitin ligase f-box and leucine-rich repeat protein 2 are suggested to prevent NLRP3 activation by directing it to the proteasome in lung epithelial cells (<xref ref-type="bibr" rid="B36">Han et al., 2020</xref>). Additionally, membrane-associated ring-ch-type finger 7, another E3 ubiquitin ligase, inhibits NLRP3 downstream of dopamine-induced D1 receptor signaling (<xref ref-type="bibr" rid="B106">Sandall and Macdonald, 2019</xref>). Another regulatory level involves phosphorylation of NLRP3 at Ser291 (or Ser295 in humans) by protein kinase A, leading to K48- and K63-linked ubiquitination and subsequent proteasomal degradation (<xref ref-type="bibr" rid="B97">Ren et al., 2019</xref>). Song et al. Demonstrated that following LPS priming, NLRP3 is phosphorylated on Ser194 by c-Jun N-terminal kinase 1, promoting NLRP3 oligomerization upon activation by canonical stimuli (<xref ref-type="bibr" rid="B111">Spalinger et al., 2023</xref>). In monocytic cells, a study revealed that dephosphorylation of NLRP3 at Tyr861 by protein tyrosine phosphatase nonreceptor 22 induces NLRP3 activation (<xref ref-type="bibr" rid="B112">Spalinger et al., 2020</xref>). Whether these pathways synergize to tightly control NLRP3 activity remains elusive.</p>
</sec>
<sec id="s3">
<title>3 Mechanisms of pyroptosis</title>
<p>Recent advances have shed light on the molecular mechanisms of pyroptosis, a form of programmed cell death induced by the agonist of the NLRP3 inflammasome (<xref ref-type="bibr" rid="B77">McKee and Coll, 2020</xref>; <xref ref-type="bibr" rid="B150">Yuan et al., 2020</xref>; <xref ref-type="bibr" rid="B22">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="B162">Zhong et al., 2023</xref>). Among these mechanisms, GSDMD has emerged as a crucial mediator of pyroptosis. GSDMD belongs to a family of proteins named GSDMs, which share a pore-forming domain (<xref ref-type="bibr" rid="B77">McKee and Coll, 2020</xref>). Cleavage of GSDMD by caspase-1 or caspase-4/5/11 releases GSDMD-NT, the NT domain of GSDMD (<xref ref-type="bibr" rid="B77">McKee and Coll, 2020</xref>). GSDMD-NT then forms these pores in the plasma membrane, leading to cell swelling and osmotic lysis (<xref ref-type="bibr" rid="B97">Ren et al., 2019</xref>). Other members of the GSDM family also possess pore-forming activity but are not targeted by inflammatory caspases (<xref ref-type="bibr" rid="B22">Chen et al., 2022</xref>). The cleavage of GSDMD occurs at a conserved residue called D276, resulting in the separation of GSDMD into two domains: GSDMD-NT (p30) and GSDMD C-terminal domain (p20) (<xref ref-type="bibr" rid="B162">Zhong et al., 2023</xref>). GSDMD-NT can interact with lipids in the plasma membrane and assemble into large oligomeric pores (<xref ref-type="bibr" rid="B150">Yuan et al., 2020</xref>). This disruption of the cell membrane integrity leads to an increase in intracellular osmotic pressure and the release of inflammatory intracellular contents, including high mobility group box-1 (HMGB-1) and heat shock protein (<xref ref-type="bibr" rid="B150">Yuan et al., 2020</xref>; <xref ref-type="bibr" rid="B17">Chan et al., 2023</xref>). This process, characterized by caspase-1-dependent cleavage of GSDMD, is known as the pyroptotic pathway (<xref ref-type="bibr" rid="B17">Chan et al., 2023</xref>).</p>
</sec>
<sec id="s4">
<title>4 Overview of exercise</title>
<p>Exercise refers to the movement of the body, typically involving the musculoskeletal system, to maintain health, improve physical fitness, promote cardiovascular health, and enhance the overall quality of life (<xref ref-type="bibr" rid="B132">Vella et al., 2017</xref>). It is a crucial component for maintaining both physical and mental wellbeing (<xref ref-type="bibr" rid="B132">Vella et al., 2017</xref>). By selecting forms of exercise that suit individual needs and goals, comprehensive health benefits can be achieved (<xref ref-type="bibr" rid="B132">Vella et al., 2017</xref>). The most common classification of exercise is based on the primary energy metabolism pathways, dividing it into aerobic and anaerobic exercise (<xref ref-type="bibr" rid="B94">Paluch et al., 2024</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Regarding the specific classification of exercise and the criteria for its determination. (HR<sub>max</sub>: maximum heart rate; VO<sub>2max</sub>: maximum volume of oxygen).</p>
</caption>
<graphic xlink:href="fphar-15-1368835-g002.tif"/>
</fig>
<p>Aerobic exercise is a form of activity that generates energy through oxidative metabolism (<xref ref-type="bibr" rid="B83">Mueller et al., 2021</xref>). This type of exercise involves relatively low to moderate intensity over an extended period to ensure the body can supply enough oxygen to support energy production (<xref ref-type="bibr" rid="B83">Mueller et al., 2021</xref>). Aerobic exercise is characterized by lower intensity, safety, rhythmic, and sustained durations, with relatively minor stress on various organs, reducing the risk of exercise-related injuries (<xref ref-type="bibr" rid="B83">Mueller et al., 2021</xref>). Common aerobic exercise programs include low-intensity continuous training (LICT) and moderate-intensity continuous training (MICT) (<xref ref-type="bibr" rid="B124">Troosters et al., 2023</xref>). The intensity of exercise is typically measured using parameters such as maximum heart rate and maximum oxygen consumption (<xref ref-type="bibr" rid="B9">Blanks et al., 2019</xref>). For maximum heart rate (HR<sub>max</sub>), low-intensity exercise falls within the 40%&#x2013;50% range, while moderate-intensity exercise falls within the 50%&#x2013;70% HR<sub>max</sub> range (<xref ref-type="bibr" rid="B9">Blanks et al., 2019</xref>). Regarding the maximum volume of oxygen (VO<sub>2max</sub>), values below 60% are considered low intensity, and those between 60% and 75% are considered moderate intensity (<xref ref-type="bibr" rid="B9">Blanks et al., 2019</xref>).</p>
<p>Anaerobic exercise involves high-intensity, momentary bursts of muscle activity in an &#x201c;oxygen-deprived&#x201d; state (<xref ref-type="bibr" rid="B62">Liao et al., 2022</xref>). It is characterized by high-intensity loads and brief durations, making it challenging to sustain for extended periods, and recovery from fatigue is slower (<xref ref-type="bibr" rid="B62">Liao et al., 2022</xref>). Anaerobic exercise enhances muscle strength, improves adaptability, and serves as a primary source of muscle growth (<xref ref-type="bibr" rid="B15">Casado et al., 2023</xref>). The intensity of anaerobic exercise is relatively high, and the sustainable duration is short, resulting in high-intensity loads that can lead to muscle fatigue and soreness (<xref ref-type="bibr" rid="B15">Casado et al., 2023</xref>). Common anaerobic exercise programs include resistance training (RT) and high-intensity interval training (HIIT) (May et al., 2020). Recently, HIIT has gained popularity as a time-efficient exercise strategy that has been proven to improve cardiovascular risk factors in various populations (May et al., 2020). This training method employs alternating patterns of work and rest to enhance cardiorespiratory endurance, promote fat burning, and provide more efficient training effects in a shorter time (May et al., 2020). High-intensity training is identified by an HR<sub>max</sub> exceeding 70% or VO<sub>2max</sub> exceeding 90% (<xref ref-type="bibr" rid="B9">Blanks et al., 2019</xref>).</p>
<p>Additionally, based on the primary training goals, exercise can be classified into endurance training (ET) and RT (<xref ref-type="bibr" rid="B27">Consitt et al., 2019</xref>). ET involves prolonged, continuous activities at relatively low loads, primarily relying on aerobic metabolism to produce energy (<xref ref-type="bibr" rid="B102">Rothschild and Bishop, 2020</xref>). It induces adaptations in the cardiovascular and musculoskeletal systems, supporting overall improvements in exercise capacity and performance (<xref ref-type="bibr" rid="B81">Miko et al., 2020</xref>). However, for older individuals who are overweight or obese, especially those with symptoms of osteoarthritis, regular ET may be uncomfortable and painful, necessitating the introduction of alternative forms of exercise (<xref ref-type="bibr" rid="B28">Cutrufello et al., 2020</xref>).</p>
<p>RT, on the other hand, offers various health benefits, supports body weight, and avoids imposing impact stress on joints (<xref ref-type="bibr" rid="B108">Schoenfeld et al., 2016</xref>). Therefore, RT may be an appealing exercise modality for overweight/obese older individuals. This type of training emphasizes resistance against external forces to enhance muscle strength, endurance, and mass, with each effort specifically targeting the resistance generated, designed to increase muscle strength and explosiveness (<xref ref-type="bibr" rid="B14">Carvalho et al., 2022</xref>).</p>
<p>Although most literature suggests that exercise can improve CVD, excessive endurance exercise (EEE) may have many potential adverse effects on cardiac structure and function (<xref ref-type="bibr" rid="B92">O&#x27;Keefe et al., 2012</xref>). Acutely, EEE can increase myocardial injury markers, lead to chamber dilation, and decrease right ventricular function (<xref ref-type="bibr" rid="B57">Levine, 2014</xref>). Chronically, concerns exist that this degree of EEE may lead to detrimental cardiac remodeling and fibrosis, as well as non-lethal arrhythmias, especially an increased risk of atrial fibrillation, and potentially more lethal ventricular arrhythmias (<xref ref-type="bibr" rid="B86">Nath et al., 2023</xref>). Recent studies also indicate that despite a more favorable overall profile of coronary heart disease risk in long-distance runners, they may have higher levels of atherosclerosis and coronary heart disease risk (<xref ref-type="bibr" rid="B88">Neumann et al., 2022</xref>; <xref ref-type="bibr" rid="B91">O&#x27;Keefe et al., 2021</xref>). However, the benefits of aerobic exercise on CVD mortality appear to be significantly diminished when running exceeds 30 miles per week or walking exceeds 46 miles per week (<xref ref-type="bibr" rid="B109">Schwartz et al., 2014</xref>). Even though that lack of physical activity is more prevalent than EEE in the overall population, the potential adverse effects may be more serious on a societal level for overall health and cardiovascular health (<xref ref-type="bibr" rid="B76">McCullough and Lavie, 2014</xref>). These studies also suggest that more is not necessarily better, and even low doses of aerobic exercise, particularly running, seem to confer benefits for long-term cardiovascular health and lifespan.</p>
</sec>
<sec id="s5">
<title>5 Mechanisms by which exercise regulates NLRP3 inflammasome activation</title>
<p>Exercise has long been acknowledged as an effective intervention in regulating the innate immune response (<xref ref-type="bibr" rid="B95">Pope and Wood, 2020</xref>). In general, LICT and MTCT have positive effects on the immune system, whereas HIIT tends to have the opposite effect (<xref ref-type="bibr" rid="B145">Xian et al., 2022</xref>). However, there is limited research on how exercise specifically influences the activity of the NLRP3 inflammasome.</p>
<p>From the perspective of material metabolism, many studies have reported that glucose and lipids can directly activate the NLRP3 inflammasome (<xref ref-type="bibr" rid="B130">Vandanmagsar et al., 2011</xref>; <xref ref-type="bibr" rid="B156">Zhang et al., 2021</xref>; <xref ref-type="bibr" rid="B4">Baik et al., 2023</xref>), while exercise can directly alleviate glucose and lipid metabolism, reducing the levels of blood sugar and lipids, thereby improving CVD. There is currently no literature reporting that exercise can directly regulate the activation pathway of NLRP3 inflammasome through glucose and lipid metabolism (<xref ref-type="bibr" rid="B73">Mardare et al., 2016</xref>; <xref ref-type="bibr" rid="B72">Ma et al., 2021</xref>). Therefore, it boldly speculates that the effect of exercise on NLRP3 inflammasome activation is likely to be exerted through the regulation of glucose and lipid metabolism.</p>
<p>From the mitochondrial standpoint, since most studies suggest that mitochondria are involved in regulating NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B24">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="B42">Hong et al., 2021</xref>), it is speculated that exercise adaptation of mitochondria may affect the NLRP3 inflammasome activity. Earlier studies demonstrated that MICT significantly decreased the expression of inflammatory cytokines TNF-&#x3b1;, IL-6, and monocyte chemoattractant protein-1 induced by metabolic disorders, coupled with an upregulation in mitochondrial proteins (<xref ref-type="bibr" rid="B63">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B23">Chen et al., 2018</xref>). Conversely, HIIT led to mitochondrial dysfunction and an augmentation in the secretion of pro-inflammatory factors (<xref ref-type="bibr" rid="B78">Memme et al., 2021</xref>). Moreover, additional investigations indicated that MICT facilitated mitochondrial biogenesis, bolstered antioxidant capacity, and restrained the overactivation of the NLRP3 inflammasome (<xref ref-type="bibr" rid="B74">Mason et al., 2020</xref>; <xref ref-type="bibr" rid="B96">Powers et al., 2020</xref>). Furthermore, aerobic exercise mitigated cardiac dysfunction by modulating the expression of proteins implicated in mitochondrial quality and NLRP3/caspase-1/IL-1&#x3b2; signaling (<xref ref-type="bibr" rid="B105">Salo et al., 1991</xref>). In pathological conditions, mitochondrial damage leads to increased production of mtROS (<xref ref-type="bibr" rid="B21">Chen et al., 2020</xref>). The elevated mtROS mediates the activation of the NLRP3 inflammasome through thioredoxin interacting protein (TXNIP) and thioredoxin (<xref ref-type="bibr" rid="B156">Zhang et al., 2021</xref>). These findings imply that MICT might diminish mitochondrial ROS production through the regulation of mitochondrial quality control, enhancement of mitochondrial function, and the facilitation of damaged mitochondria clearance. Consequently, this could inhibit the NLRP3 inflammasome pathway and alleviate exaggerated inflammatory responses.</p>
<p>From molecular mechanisms in the cell, the key factors in exercise-mediated improvement of CVD through the NLRP3 inflammasome may be related to the regulation of the NF-&#x3ba;B signaling pathway. Some studies have focused on the NF-&#x3ba;B pathway as a critical node to explore the molecular mechanisms among exercise and NLRP3 inflammasome (<xref ref-type="bibr" rid="B136">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="B165">Zhou et al., 2022</xref>). For example, research has demonstrated that aerobic exercise is capable of reducing the expression of nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4), ROS, TNF-&#x3b1;, IL-18, NF-&#x3ba;B p65, and the NLRP3 inflammasome (<xref ref-type="bibr" rid="B165">Zhou et al., 2022</xref>). These findings suggest that exercise may ameliorate the pathological alterations in diabetes mellitus through the modulation of the NOX4/ROS/NF-&#x3ba;B/NLRP3 inflammasome signaling cascade (<xref ref-type="bibr" rid="B165">Zhou et al., 2022</xref>). In a separate study, <xref ref-type="bibr" rid="B136">Wang et al., 2019</xref> observed that aerobic exercise suppresses the acetylation of forkhead box transcription factor O1 (FOXO1) in the brain tissue of diabetic rats, which in turn promotes the phosphorylation of FOXO1, thus inhibiting expression of NF-&#x3ba;B and NLRP3 inflammasome protein. This downregulation contributes to the inhibition of inflammatory responses, indicating that exercise may exert anti-inflammatory effects via the FOXO1/NF-&#x3ba;B/NLRP3 inflammasome pathway (<xref ref-type="bibr" rid="B136">Wang et al., 2019</xref>). Although studies have shown that exercise improves CVD through the NLRP3 inflammasome (Li et al., 2021; <xref ref-type="bibr" rid="B165">Zhou et al., 2022</xref>), further research is needed to elucidate the detailed molecular mechanisms by which exercise regulates the NLRP3 inflammasome.</p>
</sec>
<sec id="s6">
<title>6 Exercise, NLRP3 inflammasome, and CVD</title>
<sec id="s6-1">
<title>6.1 Exercise improves AS and inhibits NLRP3 inflammasome</title>
<p>The pathogenesis of AS involves multiple processes, including endothelial dysfunction, low-density lipoprotein accumulation and oxidation, monocyte and lymphocyte recruitment, smooth muscle cell migration and proliferation, proinflammatory cytokine activation, and platelet adhesion (<xref ref-type="bibr" rid="B152">Zeng et al., 2019</xref>). Notably, the augmented release of inflammatory cytokines primarily attributed to endothelial cells, macrophages, and smooth muscle cell pyroptosis or NLRP3 inflammasome activation significantly contributes to AS formation and development (<xref ref-type="bibr" rid="B161">Zhaolin et al., 2019</xref>). Specifically, NLRP3 inflammasome-dependent pyroptosis triggers endothelial dysfunction, thereby acting as a catalyst for AS in these cells (<xref ref-type="bibr" rid="B118">Sun et al., 2017</xref>). This highlights the crucial role of NLRP3 inflammasome in promoting the release of inflammatory mediators and contributing to the pathological changes associated with AS.</p>
<p>Exercise can reduce the inflammatory death of local endothelial cells, slowing the development of AS plaques (<xref ref-type="bibr" rid="B148">Xu et al., 2019</xref>). A study found that voluntary wheel running, a natural type of aerobic exercise in the murine model could decrease the protein levels of the inflammasome components and markedly inhibit the caspase-1 activity in endothelial cells within the aorta of mice fed with a high-fat diet (HFD) (<xref ref-type="bibr" rid="B54">Lee et al., 2020</xref>). Recently, another study has demonstrated that exercise-induced a significant downregulation of m6A modification and methyltransferase-like 14 (<xref ref-type="bibr" rid="B149">Yang et al., 2023</xref>). This protein binds to the m6A sites of nuclear paraspeckle assembly transcript 1 (NEAT1) and promotes NEAT1 expression through subsequent YT521-B homology domain-containing 1, which transcriptionally promotes NLRP3 expression and endothelial pyroptosis (<xref ref-type="bibr" rid="B149">Yang et al., 2023</xref>). As a result, exercise effectively inhibits NLRP3 expression and endothelial pyroptosis, preventing AS plaque formation (<xref ref-type="bibr" rid="B149">Yang et al., 2023</xref>). In addition, it is widely recognized that fibroblast growth factor 21 (FGF21), a well-established negative risk factor for AS expressed in the aorta, exerts inhibitory effects on NLRP3 inflammasome activity, thereby attenuating aortic pyroptosis to prevent AS development (<xref ref-type="bibr" rid="B153">Zeng et al., 2020</xref>). Interestingly, aerobic exercise increases FGF21 sensitivity while downregulating the expression of pyroptosis-related proteins mediated by NLRP3 inflammasome in the aorta (<xref ref-type="bibr" rid="B60">Li et al., 2022</xref>). These findings suggest that activated FGF21 may be involved in aerobic exercise inhibiting NLRP3 inflammasome-mediated pyroptosis in the aorta. However, the current study has not investigated whether exercise improved AS via inhibiting NLRP3 inflammasome and pyroptosis in these cells, which needs further research in the future.</p>
</sec>
<sec id="s6-2">
<title>6.2 Exercise improves HHcy and inhibits NLRP3 inflammasome</title>
<p>Homocysteine (Hcy), a non-essential amino acid sulfur, is derived from methionine and is used for methylation of DNA/RNA methylation (<xref ref-type="bibr" rid="B131">Veeranki and Tyagi, 2013</xref>). HHcy refers to a condition where plasma Hcy levels exceed 15&#xa0;&#x3bc;mol/L and has been associated with various diseases especially AS (<xref ref-type="bibr" rid="B140">Winchester et al., 2014</xref>). HHcy promotes the generation of ROS through mechanisms such as mixed disulfide formation and auto-oxidation (<xref ref-type="bibr" rid="B131">Veeranki and Tyagi, 2013</xref>; <xref ref-type="bibr" rid="B140">Winchester et al., 2014</xref>). Recent research has demonstrated that HHcy-induced activation of the NLRP3 inflammasome in macrophages contributes to vascular inflammation and AS by activating caspase-1-mediated pyroptosis (<xref ref-type="bibr" rid="B137">Wang et al., 2017</xref>). In addition, acid sphingomyelinase upregulation by Hcy promotes clustering of lipid rafts mediating the assembly of NADPH oxidase complex resulting in increased ROS generation followed by NLRP3 inflammasome activation leading to pyroptosis contributing towards the development of AS (<xref ref-type="bibr" rid="B65">Liu et al., 2022</xref>).</p>
<p>Although direct evidence is currently lacking regarding whether exercise specifically modulates NLRP3 inflammasome activation or pyroptosis about HHcy, it has been observed that exercise can lower Hcy levels (<xref ref-type="bibr" rid="B65">Liu et al., 2022</xref>). In a folate-restricted model of HHcy, exercise can reduce the increase in plasma Hcy levels by increasing betaine Hcy s-methyltransferase levels in the kidneys and promoting nonclassical remethylation to convert Hcy into methionine (<xref ref-type="bibr" rid="B133">Vincent et al., 2006</xref>; <xref ref-type="bibr" rid="B87">Neuman et al., 2013</xref>). Moreover, apart from reducing plasma Hcy levels, exercise holds the potential for mitigating Hcy-induced lipid peroxidation and ameliorating reductions in superoxide dismutase and catalase activity, both of which are implicated in the progression of AS (<xref ref-type="bibr" rid="B87">Neuman et al., 2013</xref>). These works suggest that exercise might also inhibit NLRP3 inflammasome activation or pyroptosis as a part of its overall impact on reducing HHcy-related complications. Given these findings, further investigation is warranted to explore whether exercise precisely influences NLRP3 inflammasome activation or pyroptosis and their role in HHcy management. Understanding this relationship could provide valuable insights into developing targeted interventions for individuals with elevated Hcy levels and associated CVD.</p>
</sec>
<sec id="s6-3">
<title>6.3 Exercise improves obesity and inhibits NLRP3 inflammasome</title>
<p>Obesity, commonly associated with chronic low-grade inflammation, is characterized by the pathological enlargement of adipose tissue (AT) primarily due to excess energy accumulation as fat (<xref ref-type="bibr" rid="B110">Spalding et al., 2008</xref>; <xref ref-type="bibr" rid="B134">Wada et al., 2017</xref>). Mice with HFD-induced obesity exhibit increased expression of caspase-1, ASC, and NLRP3. However, knocking out the <italic>Nlrp3</italic> or <italic>Caspase-1</italic> gene suppresses obesity-induced fat depot (<xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>). Therefore, targeting the activation of NLRP3 inflammasome or pyroptosis represents a promising approach for improving obesity.</p>
<p>A study found that exercise decreased protein expression of inflammasome components (NLRP3 and caspase-1) in bone marrow-derived macrophages (BMDM) and AT isolated from mice with diet-induced obesity (<xref ref-type="bibr" rid="B44">Javaid et al., 2021</xref>). Another study investigated perform mice fed either a standard diet or an HFD and subjected to regular ET or RT and discovered that RT attenuated increased NLRP3 expression and reduced levels of IL-18 in isolated AT, while ET effectively reduced the expression of TNF-&#x3b1; and IL-18 in supernatant from AT, suggesting that exercise can reduce inflammasome activation in ATs and achieve systemic downregulation of inflammatory cytokines (<xref ref-type="bibr" rid="B134">Wada et al., 2017</xref>). Besides AT, endothelial dysfunction emerges early on in CVD associated with obesity (<xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>; <xref ref-type="bibr" rid="B134">Wada et al., 2017</xref>). A study demonstrated that engaging in voluntary running while on an HFD led to a significant reduction in active caspase-1 levels within the endothelial cells lining the aorta when compared to sedentary mice on the same diet (<xref ref-type="bibr" rid="B59">Li et al., 2023</xref>). These findings indicate that voluntary running alleviates impaired blood vessel function via inhibiting NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B59">Li et al., 2023</xref>). In addition to endothelial cells, exercise suppressed NLRP3 inflammasome activation as revealed by downregulated IL-1&#x3b2; and IL-18 in BMDM (<xref ref-type="bibr" rid="B59">Li et al., 2023</xref>). This body of research demonstrates that exercise exerts inhibitory effects on NLRP3 inflammasome activation across various cell types to ameliorate obesity.</p>
<p>It&#x2019;s worth noting that a human study found that exercise reduces plasma IL-18 levels in obese individuals, indirectly suggesting the inhibition of the NLRP3 pathway through exercise to improve obesity (<xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>). Furthermore, 8-week high-intensity and aerobic interval training (three times/week) in men and women with metabolic syndrome resulted in decreased IL-18 mRNA levels in abdominal AT and a numerical decrease in plasma IL-18 concentration (<xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>; <xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>; <xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>; <xref ref-type="bibr" rid="B114">Stienstra et al., 2011</xref>). Similarly, a pilot study, conducted among thirty-seven obese individuals demonstrates that exercise intervention, primarily consisting of activities such as walking, jogging, and functional exercise circuits designed to enhance aerobic capacity and speed, leads to significant reductions in ASC mRNA expression levels when compared to the hypocaloric group without any form of exercise participation (<xref ref-type="bibr" rid="B6">Barr&#xf3;n et al., 2020</xref>). These findings indicate an inverse relationship between ASC mRNA expression and aerobic interventions. Another randomized controlled trial involving 36 obese inactive subjects further delineated the type of exercise intervention and demonstrated both HIIT and MICT significantly reduced NLRP3 gene expression in serum samples from all subjects, strongly suggesting that diversity intensity interval training can inhibit NLRP inflammasome in obese (<xref ref-type="bibr" rid="B3">Armannia et al., 2022</xref>).</p>
<p>Therefore, exercise is considered a crucial strategy for reducing inflammation and metabolic disorders associated with obesity. Further research will enhance understanding of the complex relationship between exercise and NLRP3 inflammasome, leading to more effective interventions for managing obesity-related diseases.</p>
</sec>
<sec id="s6-4">
<title>6.4 Exercise improves diabetes and inhibits NLRP3 inflammasome</title>
<p>Diabetes is a metabolic disease that poses a significant threat to human health. Type 2 diabetes, a significant risk factor for both microvascular and macrovascular diseases, accounts for 90% of diabetes cases and is a leading cause of death, particularly due to coronary heart disease (<xref ref-type="bibr" rid="B33">Einarson et al., 2018</xref>). Inflammatory processes play a crucial role in the development of complications associated with diabetes (<xref ref-type="bibr" rid="B101">Roncero-Ramos et al., 2018</xref>). Recently, NLRP3 inflammasome and pyroptosis have emerged as key contributors to insulin resistance (IR) (<xref ref-type="bibr" rid="B101">Roncero-Ramos et al., 2018</xref>). Peripheral blood-derived macrophages from drug-na&#xef;ve patients with type 2 diabetes show increased expression of NLRP3 and ASC along with caspase-1 activation and IL-1&#x3b2; maturation (<xref ref-type="bibr" rid="B53">Lee et al., 2013</xref>). <italic>In vivo</italic> and <italic>in vitro</italic> studies have reported that high glucose stimulates IL-1&#x3b2; secretion in pancreatic &#x3b2; cells, resulting in their death through the activation of NLRP3 inflammasome (<xref ref-type="bibr" rid="B163">Zhou et al., 2010</xref>; <xref ref-type="bibr" rid="B142">Wu et al., 2019</xref>). The various modes of activating the NLRP3 inflammasome are fundamental factors influencing its complex effects on the progression of type 2 diabetes (<xref ref-type="bibr" rid="B25">Chen et al., 2021</xref>).</p>
<p>Engaging in aerobic exercise can improve IR and reduce the expression of NLRP3 and IL-1&#x3b2; in individuals with type 2 diabetes in aortic tissue, suggesting its positive impact on IR by inhibiting NLRP3 inflammasome (<xref ref-type="bibr" rid="B37">Hassanpour Soleimani et al., 2021</xref>). HMGB1 is a major pro-inflammatory cytokine released as a result of pyroptosis (<xref ref-type="bibr" rid="B8">Biguetti et al., 2019</xref>). This work also found that exercise can reduce the secretion of HMGB1, which is significantly increased in individuals with diabetes and contributes to disease progression (<xref ref-type="bibr" rid="B37">Hassanpour Soleimani et al., 2021</xref>). Previous studies have shown that exercise has the potential to lower HMGB-1 levels in circulation and tissues of diabetic patients, possibly by inhibiting NLRP3 inflammasome activation and pyroptosis (<xref ref-type="bibr" rid="B39">Ha&#xdf; et al., 2022</xref>; <xref ref-type="bibr" rid="B38">Ha&#xdf; et al., 2023</xref>). Furthermore, exercise decreased circulating levels of IL-1, which may potentially protect against IL-1-mediated destruction of &#x3b2;-cells (<xref ref-type="bibr" rid="B116">Stumvoll et al., 2005</xref>). Although there is currently no direct evidence on whether aerobic exercise specifically affects NLRP3 inflammasome activation or pyroptosis and thus decreases levels of blood glucose, these findings highlight the significant role played by exercise in regulating IR through its impact on NLRP3 inflammasome and pyroptosis.</p>
</sec>
<sec id="s6-5">
<title>6.5 Exercise improves DCM and inhibits NLRP3 inflammasome</title>
<p>DCM is a distinct cardiac phenotype observed in diabetic patients characterized by structural changes such as cardiac hypertrophy, cardiomyocyte death, and fibrosis, as well as functional abnormalities (<xref ref-type="bibr" rid="B117">Sun et al., 2021</xref>). The molecular mechanisms underlying DCM involve various factors including hyperglycemia, IR, fatty acids, oxidative stress, mitochondrial dysfunction, inflammation, and endothelial dysfunction (<xref ref-type="bibr" rid="B21">Chen et al., 2020</xref>). In particular, inflammation is believed to be present in the early stages of diabetes and plays a crucial role in promoting DCM (<xref ref-type="bibr" rid="B68">Luo et al., 2017</xref>). Emerging evidence has verified that NLRP3 inflammasome-mediated cardiomyocyte pyroptosis is a key participant in DCM (<xref ref-type="bibr" rid="B146">Xie et al., 2020</xref>). Human diabetic hearts also exhibit elevated activation of the NLRP3 inflammasome and cardiac pyroptosis compared to non-diabetic heart tissues (<xref ref-type="bibr" rid="B155">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="B146">Xie et al., 2020</xref>). Moreover, high glucose levels (35&#xa0;mM) significantly induce increased protein expression of NLRP3, caspase-1, and IL-1&#x3b2; accompanied by noticeable cardiomyocyte pyroptosis, leading to loss of contractile units and cardiac dysfunction (<xref ref-type="bibr" rid="B155">Zhang et al., 2015</xref>). In contrast, silencing the <italic>Nlrp3</italic> gene ameliorates cardiac inflammation and pyroptosis and improves cardiac function by ameliorating cardiac inflammation and pyroptosis both <italic>in vivo</italic> and <italic>in vitro</italic> experiments (<xref ref-type="bibr" rid="B21">Chen et al., 2020</xref>).</p>
<p>Exercise intervention has been shown to effectively prevent and treat DCM by modulating the NLRP3 inflammasome. For example, the expressions of NLRP3, caspase-1-p20, caspase-1p20/caspase-1, and IL-1&#x3b2; were increased in the myocardium of HFD-induced obese mice (<xref ref-type="bibr" rid="B55">Lee et al., 2018</xref>). However, treadmill exercise inhibited these parameters (<xref ref-type="bibr" rid="B117">Sun et al., 2021</xref>). This demonstrates that exercise training can prevent obesity-induced cardiac inflammasome formation, pyroptosis activation, and pro-inflammatory response (<xref ref-type="bibr" rid="B117">Sun et al., 2021</xref>). In addition, recent studies in DCM mice have demonstrated that although exercise has a limited impact on interstitial fibrosis, it can effectively reverse cardiac dysfunction by reducing the activity of NLRP3 inflammasome and inhibiting pyroptosis (<xref ref-type="bibr" rid="B121">Takahashi, 2019</xref>; <xref ref-type="bibr" rid="B154">Zhang et al., 2019</xref>). Moreover, in DCM rat models, elevated expression levels of the P2X7 receptor, NLRP3, caspase-1, and serum IL-1&#x3b2; were observed in the myocardium (<xref ref-type="bibr" rid="B138">Wang et al., 2022</xref>). However, following a 12-week treadmill running regimen in these rats, improvements were observed in terms of collagen deposition, cell disorder, as well as the expression levels of NLRP3, caspase-1, P2X7 receptor, and IL-1&#x3b2; within their heart (<xref ref-type="bibr" rid="B155">Zhang et al., 2015</xref>). Similarly, aerobic exercise also can inhibit the thioredoxin interacting protein (TXNIP)/NLRP3 inflammasome pathway and alleviate endothelial dysfunction in atherosclerotic coronary arterioles (<xref ref-type="bibr" rid="B41">Hong et al., 2018</xref>). These findings suggest that aerobic exercise can effectively mitigate fibrosis in the hearts subjected to an HFD and inhibit the activation of the NLRP3 inflammasome and pyroptosis in the myocardium. The effectiveness of exercise intervention on the NLRP3 inflammasome depends on the duration and intensity of exercise (<xref ref-type="bibr" rid="B41">Hong et al., 2018</xref>; <xref ref-type="bibr" rid="B47">Khakroo et al., 2019</xref>). Chronic exercise with moderate intensity significantly decreases the expression of the NLRP3 gene and levels of IL-1&#x3b2;, and IL-18 cytokines in serum (<xref ref-type="bibr" rid="B47">Khakroo et al., 2019</xref>). Conversely, chronic exercise with high intensity leads to a significant increase in gene expression of NLRP3 and levels of IL-1&#x3b2;, and IL-18 cytokines in serum (<xref ref-type="bibr" rid="B47">Khakroo et al., 2019</xref>). Therefore, personalized exercise regimens are necessary as there are currently no available guidelines; further research is needed.</p>
</sec>
<sec id="s6-6">
<title>6.6 Exercise improves hypertension and inhibits NLRP3 inflammasome</title>
<p>Hypertension is a potentially fatal yet preventable risk factor for CVD and accounts for the majority of cardiovascular mortality (<xref ref-type="bibr" rid="B30">Deussen and Kopaliani, 2023</xref>). Persistent inflammation plays a pivotal role in hypertension development, with activation of the inflammasome and pyroptosis being potential contributors to its onset (<xref ref-type="bibr" rid="B29">De et al., 2021</xref>). NLRP3 inflammasome activities have been implicated in various cell types associated with pulmonary hypertension, including pulmonary arterial smooth muscle cells, pulmonary artery endothelial cells, and systemic hypertension (<xref ref-type="bibr" rid="B38">Ha&#xdf; et al., 2023</xref>). Additionally, higher serum levels of IL-1&#x3b2; were observed in patients with hypertension compared to normotensive controls (<xref ref-type="bibr" rid="B143">Wu et al., 2022</xref>).</p>
<p>Exercise is commonly suggested as a lifestyle adjustment for individuals with hypertension due to various factors including inhibition of inflammation (<xref ref-type="bibr" rid="B89">Newman and Verdin, 2014</xref>; <xref ref-type="bibr" rid="B16">Chakraborty et al., 2018</xref>; <xref ref-type="bibr" rid="B49">Kong et al., 2021</xref>). &#x3b2;-Hydroxybutyrate (&#x3b2;-OHB) ester is primarily synthesized in the liver and transported to extrahepatic tissues, traditionally recognized as a crucial metabolic fuel during starvation periods (<xref ref-type="bibr" rid="B89">Newman and Verdin, 2014</xref>). Contemporary evidence indicates that ketone bodies like &#x3b2;-OHB can maintain physiological homeostasis by inhibiting NLRP3-inflammasome-mediated inflammation (<xref ref-type="bibr" rid="B49">Kong et al., 2021</xref>). Recently, a non-targeted metabolomics approach revealed nutritional intervention with &#x3b2;-OHB reversed the high salt-induced adverse effects including renal NLRP3-mediated inflammation, fibrosis, and hypertension (<xref ref-type="bibr" rid="B16">Chakraborty et al., 2018</xref>). Interestingly, exercise is associated with increased circulating levels of &#x3b2;-OHB (<xref ref-type="bibr" rid="B70">Luo et al., 2021</xref>). Therefore, exercise may raise &#x3b2;-OHB levels and subsequently inhibit renal NLRP3 inflammasome activation, thereby alleviating hypertension and preserving kidney function. Another <italic>in vivo</italic> study provided direct evidence of the impact of exercise training on the downregulation of NF-&#x3ba;B and NLRP3 pathways in the mesenteric artery of spontaneously hypertensive rats (SHR) (<xref ref-type="bibr" rid="B70">Luo et al., 2021</xref>), which revealed that three intensity training intensities from low to high significantly inhibited the expression of NLRP3 inflammasome component and NF-&#x3ba;B within the mesenteric artery and alleviate BP in SHR rat (<xref ref-type="bibr" rid="B70">Luo et al., 2021</xref>). In addition to the SHR rat model, <xref ref-type="bibr" rid="B5">Bal et al., 2022</xref> discovered that regulated aerobic exercise also effectively reduces BP and suppresses protein expression of NLRP3, IL-1&#x3b2;, and caspase-1 in the heart within the deoxycorticosterone-acetate salt hypertension model. These findings from the diversity hypertension model demonstrate that exercise training effectively attenuates NLRP3 inflammasome activity, highlighting its potential as a therapeutic intervention for hypertension.</p>
</sec>
<sec id="s6-7">
<title>6.7 Exercise improves MI and inhibits NLRP3 inflammasome</title>
<p>MI, a common condition, refers to the death of heart muscle cells caused by a blockage in the coronary arteries (<xref ref-type="bibr" rid="B135">Wang et al., 2020</xref>). Following a heart attack, inflammatory reactions occur, characterized by the release of inflammatory cells, cytokines, and chemical hormones (<xref ref-type="bibr" rid="B80">Mezzaroma et al., 2011</xref>; <xref ref-type="bibr" rid="B135">Wang et al., 2020</xref>). These processes contribute to cardiac dysfunction, damage to the heart muscle, and remodeling (<xref ref-type="bibr" rid="B80">Mezzaroma et al., 2011</xref>; <xref ref-type="bibr" rid="B135">Wang et al., 2020</xref>). Indeed, NLRP3 inflammasome and pyroptosis-mediated inflammation have been reported to contribute to MI progression (<xref ref-type="bibr" rid="B107">Sandanger et al., 2013</xref>). <xref ref-type="bibr" rid="B107">Sandanger et al., 2013</xref> first showed an increase in NLRP3 inflammasome activity in the left ventricle of the heart after MI. Furthermore, it appears that interfering with NLRP3 inflammasome signaling can prevent and mitigate damage caused by MI (<xref ref-type="bibr" rid="B107">Sandanger et al., 2013</xref>).</p>
<p>The research has shown that exercise training can delay the onset of ischemic reperfusion injury and MI (<xref ref-type="bibr" rid="B123">Thomas et al., 2016</xref>). In other words, exercise acts like ischemia preconditioning, which stimulates beneficial cellular responses. Azam <xref ref-type="bibr" rid="B1">Ahmadi et al., 2022</xref> found HIIT can effectively decrease heart injury and NLRP3 expression in rats with MI. Interestingly, dynamin-related protein 1 (Drp1), an essential mitochondrial fission protein, can activate NLRP3 inflammasome through ROS generation after MI (<xref ref-type="bibr" rid="B1">Ahmadi et al., 2022</xref>; <xref ref-type="bibr" rid="B45">Jiang et al., 2022</xref>). However, the Azam Ahmadi team&#x2019;s work demonstrates exercise preconditioning (EP) in a short period did not affect Drp1 (<xref ref-type="bibr" rid="B1">Ahmadi et al., 2022</xref>), while inhibiting NLRP3 expression. This finding indicates that EP in a short period is required to inhibit NLRP3 inflammasome independently of Drp1; the reduction of NLRP3 can occur through other mechanisms (<xref ref-type="bibr" rid="B45">Jiang et al., 2022</xref>).</p>
</sec>
<sec id="s6-8">
<title>6.8 Exercise affects HF and regulates NLRP3 inflammasome</title>
<p>HF means that the heart is unable to pump sufficiently to sustain blood flow to meet the needs of the body (<xref ref-type="bibr" rid="B104">Sacco et al., 2014</xref>). It represents the advanced stage of various CVD, including myocarditis, MI, cardiomyopathy, hypertension, atrial fibrillation, valvular heart disease, alcohol abuse, and infection (<xref ref-type="bibr" rid="B12">Bracey et al., 2013</xref>). Recent studies on calcineurin transgene mice have shown elevated mRNA of NLRP3 and enhanced cleavage of caspase-1 along with cardiac hypertrophy and ventricular dilatation (<xref ref-type="bibr" rid="B12">Bracey et al., 2013</xref>; <xref ref-type="bibr" rid="B85">Napodano et al., 2023</xref>). Genetic ablation of NLRP3 or administration of IL-1 receptor antagonist has been found to attenuate cardiac inflammation and systolic dysfunction (<xref ref-type="bibr" rid="B12">Bracey et al., 2013</xref>; <xref ref-type="bibr" rid="B158">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="B85">Napodano et al., 2023</xref>). Additionally, activation of NLRP3 inflammasome has been observed in LPS-stimulated cardiac fibroblasts and myofibroblasts, suggesting that its potential contribution to myocardial dysfunction through NLRP3 inflammasome or pyroptosis (<xref ref-type="bibr" rid="B158">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="B11">Boza et al., 2016</xref>). Although more research is needed to fully understand how the NLRP3 inflammasome or pyroptosis contributes to HF pathogenesis and progression; recent studies indicate that targeting this pathway could lead to new treatments for this debilitating condition (<xref ref-type="bibr" rid="B67">Lu et al., 2022</xref>; <xref ref-type="bibr" rid="B147">Xin et al., 2022</xref>).</p>
<p>Studies have shown that EP can regulate the NLRP3 inflammasome, reducing downstream inflammatory cytokines and protecting the heart (<xref ref-type="bibr" rid="B61">Li et al., 2020</xref>; <xref ref-type="bibr" rid="B72">Ma et al., 2021</xref>; <xref ref-type="bibr" rid="B157">Zhang et al., 2022</xref>). <xref ref-type="bibr" rid="B61">Li et al., 2020</xref> found that moderate-intensity EP is more effective in protecting cardiac function and inhibiting the expression of TXNIP, NLRP3, NF-&#x138;B p65, and caspase-1 in the heart. As expected with moderate-intensity exercise, 8&#xa0;weeks of aerobic exercise at this level inhibited protein expression related to myocardial NLRP3/caspase-1/IL-1&#x3b2; signaling pathways in mice with myocardial hypertrophy (<xref ref-type="bibr" rid="B72">Ma et al., 2021</xref>). In addition, <xref ref-type="bibr" rid="B107">Sandanger et al., 2013</xref> show that the NLRP3 inflammasome is upregulated in myocardial fibroblasts post-MI, and maybe a significant contributor to infarct size development during ischemia-reperfusion. These findings highlight the potential therapeutic value of moderate-intensity exercise for cardiovascular health. However, exhaustive exercise (EE), characterized by sustained high-intensity exercise commonly practiced by athletes and soldiers alike, may lead to adverse reactions such as myocardial inflammation. It is reported that EE can increase NLRP3 expression and induce cardiac dysfunction which can be mitigated by EP at different intensities (<xref ref-type="bibr" rid="B155">Zhang et al., 2015</xref>). Importantly, moderate-intensity EP has cardioprotective effects on ventricular systolic and diastolic functions, indicating its superior efficacy compared to other intensities (<xref ref-type="bibr" rid="B158">Zhang et al., 2014</xref>).</p>
<p>Importantly, a clinical trial with 54 HF patients showed that exercise increased ASC methylation, decreased IL-1&#x3b2; and ASC mRNA levels compared to the control group in plasma, suggesting that exercise may improve HF via epigenetic regulation of ASC (<xref ref-type="bibr" rid="B13">Butts et al., 2018</xref>). Recently, our research team has reported for the first time that NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy in cellular, murine, and human models (<xref ref-type="bibr" rid="B153">Zeng et al., 2020</xref>). Furthermore, numerous studies have investigated exercise intervention in patients with dilated cardiomyopathy and have demonstrated its safety and efficacy in improving exercise capacity and quality of life among these individuals (<xref ref-type="bibr" rid="B115">Stolen et al., 2003</xref>; <xref ref-type="bibr" rid="B7">Beer et al., 2008</xref>). Consequently, it is meaningful to investigate whether exercise can exert inhibitory effects on NLRP3 inflammasome activation and subsequent pyroptotic cell death in dilated cardiomyopathy. Preliminary data suggest that exercise may effectively inhibit NLRP3 inflammasome activation in dilated cardiomyopathy (unpublished data).</p>
<p>Although these experiments indicate that exercise improves HF by inhibiting NLRP3 inflammasome activation, there is still debate (<xref ref-type="bibr" rid="B13">Butts et al., 2018</xref>). For example, previous work reported that exercise training consisting of three sessions per week lasting for 60&#xa0;min each, including aerobic exercises, strength exercises targeting major muscle groups, and stretching exercises have no effect on serum levels of pro-inflammatory cytokines (TNF-&#x3b1;, IL-1&#x3b2;, IL-8, and monocyte chemoattractant protein-1) of patients with severe Chagas cardiomyopathy (<xref ref-type="bibr" rid="B100">Rodrigues Junior et al., 2020</xref>), suggesting that exercise training may benefit patients with severe Chagas cardiomyopathy independent of its impact on inflammasome (<xref ref-type="bibr" rid="B100">Rodrigues Junior et al., 2020</xref>).</p>
<p>Most studies suggest that exercise improves HF by inhibiting the activation of NLRP3 inflammasomes. Nevertheless, a minority of research suggests that engaging in activities like EE might potentially worsen the progression of HF. It is imperative for future investigations to thoroughly examine the role played by NLRP3 inflammasome activation in exercise-induced exacerbation of HF.</p>
</sec>
</sec>
<sec id="s7">
<title>7 Summary and prospects</title>
<p>Exercise plays an important regulatory role in the development of various CVD by influencing the activation of the NLRP3 inflammasome (<xref ref-type="fig" rid="F3">Figure 3</xref>). This impact has been observed in different types of cells and tissues, both <italic>in vivo</italic> and <italic>in vitro</italic> models of CVD (<xref ref-type="table" rid="T1">Table 1</xref>). This review highlights the close relationship between aerobic exercise, NLRP3 inflammasome, and CVD. It suggests that aerobic exercise can alleviate pyroptosis and improve cardiovascular-related diseases by modulating the NLRP3 inflammatory signaling pathway. Different patterns of exercise have varying impacts on the NLRP3 inflammasome; therefore, further research is needed to determine their optimal effects on specific types of cells and their underlying molecular mechanisms involving the NLRP3 inflammasome. Currently, there is a greater emphasis on animal experiments investigating the influence of exercise on NLRP3 inflammasome or cell pyroptosis while human studies are limited with small sample sizes in this area. Conducting comprehensive research on humans would provide a scientifically sound basis for understanding how exercise regulates NLRP3 inflammasome activity and promotes overall health. Hence, there is a need for methodologically rigorous large-scale human studies to determine ideal patterns of exercise.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Exercise intervention affects cardiovascular disease by NLRP3 inflammasome-mediated pyroptosis. The activation of NLRP3 inflammasome induces pyroptosis, which promotes vascular inflammation and heart remodeling, and ultimately leads to cardiovascular diseases. Exercise affects the progression of cardiovascular diseases by inhibiting the activation of the NLRP3 inflammasome.</p>
</caption>
<graphic xlink:href="fphar-15-1368835-g003.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Types of cells and tissue injury subjected to NLRP3 inflammasome by exercise intervention in various CVD.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Diseases</th>
<th align="left">Exercise type</th>
<th align="left">Specific exercise intervention</th>
<th align="left">Cell types/Organ</th>
<th align="left">Injury types</th>
<th align="left">Effects</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">AS</td>
<td align="left">Aerobic exercise</td>
<td align="left">Long-distance walking for at least 60&#xa0;min at least 5 days a week</td>
<td align="left">Human plasma&#x2a;</td>
<td align="left"/>
<td align="left">NLRP3 inflammasome inactivation</td>
<td align="left">
<xref ref-type="bibr" rid="B149">Yang et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">AS</td>
<td align="left">Aerobic exercise</td>
<td align="left">Run on a motorized rodent treadmill 5 days a week</td>
<td align="left">Mouse plasma, heart, and aortic endothelial cells</td>
<td align="left">HFD</td>
<td align="left">NLRP3 inflammasome inactivation</td>
<td align="left" style="color:#1F497D">(Yang et al., 2023)</td>
</tr>
<tr>
<td align="left">AS</td>
<td align="left">Aerobic exercise</td>
<td align="left">Treadmill exercise training for 12 weeks</td>
<td align="left">Serum, the aorta, and the right lobe of the liver</td>
<td align="left">HFD</td>
<td align="left">FGF21 and NLRP3 inflammasome-mediated pyroptosis</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Li et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">HHcy</td>
<td align="left">Aerobic exercise</td>
<td align="left">Wheel-exercised mice had free access to their wheels 24&#xa0;h/d for 5&#xa0;days/wk</td>
<td align="left">Plasma, liver tissue, and kidney</td>
<td align="left">AIN-93G semi-purified diet</td>
<td align="left">Exercise reduced circulating Hcy, which may affect NLRP3 inflammasome-mediated pyroptosis</td>
<td align="left">
<xref ref-type="bibr" rid="B87">Neuman et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Endurance training or resistance training</td>
<td align="left">at 0.15&#xa0;m/s, increasing every 3&#xa0;min by 0.05&#xa0;m/s; for 5 times/week for 3&#xa0;min and 3 series</td>
<td align="left">Mouse adipose tissue and serum</td>
<td align="left">HFD</td>
<td align="left">NLRP3 expression, levels of TNF-&#x3b1; and IL-18</td>
<td align="left">
<xref ref-type="bibr" rid="B73">Mardare et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise</td>
<td align="left">Treadmill exercise for 8 weeks</td>
<td align="left">Adipose tissue and bone marrow-derived macrophages</td>
<td align="left">HFD</td>
<td align="left">NLRP3 inflammasome</td>
<td align="left">
<xref ref-type="bibr" rid="B44">Javaid et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise</td>
<td align="left">Running wheel access</td>
<td align="left">Endothelial cells of the aorta</td>
<td align="left">HFD</td>
<td align="left">Activation of NLRP3 inflammasome</td>
<td align="left">
<xref ref-type="bibr" rid="B53">Lee et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise and resistance training</td>
<td align="left">High-intensity aerobic interval training and strength training</td>
<td align="left">Human serum&#x2a;</td>
<td align="left"/>
<td align="left">IL-18, IL-6, and TNF-&#x3b1;</td>
<td align="left">
<xref ref-type="bibr" rid="B113">Stensvold et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise</td>
<td align="left">12 weeks of intervention with exercise</td>
<td align="left">Human serum&#x2a;</td>
<td align="left">4 subjects with metabolic syndrome</td>
<td align="left">IL-18</td>
<td align="left" style="color:#1F497D">(Troseid et al., 2009)</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise</td>
<td align="left">Hypocaloric diet exercise</td>
<td align="left">Human peripheral blood&#x2a;</td>
<td align="left"/>
<td align="left">ASC gene expression and IL-1&#x3b2;</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Barr&#xf3;n et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Obesity</td>
<td align="left">Aerobic exercise</td>
<td align="left">High-intensity interval and moderate-intensity continuous training</td>
<td align="left">Human serum samples&#x2a;</td>
<td align="left"/>
<td align="left">The expression of NLRP3</td>
<td align="left">
<xref ref-type="bibr" rid="B3">Armannia et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">Diabetes</td>
<td align="left">Aerobic exercise</td>
<td align="left">A treadmill for 6 weeks, 5 sessions per week</td>
<td align="left">Rats adipose tissue and aortic tissue sampling</td>
<td align="left">Streptozotocin</td>
<td align="left">HMGB1 gene expression</td>
<td align="left">
<xref ref-type="bibr" rid="B37">Hassanpour et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">DCM</td>
<td align="left">Aerobic exercise</td>
<td align="left">A motor treadmill running speed was increased until the speed reached 10&#xa0;m/min</td>
<td align="left">The heart and serum</td>
<td align="left">HFD</td>
<td align="left">The expression of P2X7R, NLRP3, caspase-1 and IL-1&#x3b2;</td>
<td align="left">
<xref ref-type="bibr" rid="B25">Chen et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">DCM</td>
<td align="left">Aerobic exercise</td>
<td align="left">1&#xa0;h of running on a motor-driven treadmill at 15&#xa0;m/min at a 5&#xb0; grade, 5 days/week for 15&#x2013;16 weeks</td>
<td align="left">Heart tissue and isolated coronary arteriole</td>
<td align="left">A western atherogenic diet (0.2% cholesterol, 42% Kcal from fat)</td>
<td align="left">NLRP3 inflammasome inactivation</td>
<td align="left">
<xref ref-type="bibr" rid="B41">Hong et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Hypertension</td>
<td align="left">Aerobic exercise</td>
<td align="left">High-intensity exercise</td>
<td align="left">Serum and kidneys</td>
<td align="left">High salt-diet</td>
<td align="left">Upregulated &#x3b2;-OHB</td>
<td align="left">
<xref ref-type="bibr" rid="B16">Chakraborty et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Hypertension</td>
<td align="left">Aerobic exercise</td>
<td align="left">A treadmill for 14 weeks, 5 times a week and 60&#xa0;min each time</td>
<td align="left">Blood, vascular tissue samples, and mesenteric artery</td>
<td align="left">Wistar Kyoto rats</td>
<td align="left">NF-&#x3ba;B/NLRP3 inflammatory pathway</td>
<td align="left">
<xref ref-type="bibr" rid="B70">Luo et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Hypertension</td>
<td align="left">Aerobic exercise</td>
<td align="left">A 45-min running on a horizontal treadmill at 20&#xa0;m/min, 5 days per week</td>
<td align="left">Systolic blood pressure and the left ventricle tissues</td>
<td align="left">Deoxycorticosterone-acetate and salt administration</td>
<td align="left">NLRP3 inflammasome activation</td>
<td align="left">
<xref ref-type="bibr" rid="B5">Bal et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">MI</td>
<td align="left">Aerobic exercise and anaerobic exercise</td>
<td align="left">10&#x2a;1-min running intervals were separated by a 2-min rest</td>
<td align="left">Blood samples from the heart and heart tissue</td>
<td align="left">Isoproterenol</td>
<td align="left">NLRP3 inflammasome</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Ahmadi et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">HF</td>
<td align="left">Aerobic exercise</td>
<td align="left">Low-, middle-, and high-intensity exercise</td>
<td align="left">Serum and myocardial specimens</td>
<td align="left">refer to Bedford&#x2019;s motion load standard</td>
<td align="left">NF-&#x138;B p65/NLRP3 inflammatory</td>
<td align="left">
<xref ref-type="bibr" rid="B61">Li et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">HF</td>
<td align="left">Aerobic exercise</td>
<td align="left">2, 4, and 8 weeks of moderate-intensity aerobic exercise</td>
<td align="left">Mouse heart tissues</td>
<td align="left">Transverse aortic constriction</td>
<td align="left">NLRP3/caspase-1/IL-1&#x3b2; signaling pathways</td>
<td align="left">
<xref ref-type="bibr" rid="B72">Ma et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">HF</td>
<td align="left">Aerobic exercise</td>
<td align="left">A treadmill for 90&#xa0;min/day and 6 days/week for 6 weeks at a velocity of 15&#xa0;cm/s</td>
<td align="left">Mouse hearts and primary neonatal mouse cardiomyocytes</td>
<td align="left">Isoprenaline</td>
<td align="left">NLRP3 inflammasome</td>
<td align="left">
<xref ref-type="bibr" rid="B157">Zhang et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">HF</td>
<td align="left">Aerobic exercise</td>
<td align="left">A progressive, moderate intensity aerobic protocol</td>
<td align="left">Human plasma&#x2a;</td>
<td align="left"/>
<td align="left">IL-1&#x3b2; and ASC mRNA gene expression</td>
<td align="left">
<xref ref-type="bibr" rid="B13">Butts et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">HF</td>
<td align="left">Aerobic exercise</td>
<td align="left">Three times a week, 60&#xa0;min/session, for 8 months</td>
<td align="left">Human serum&#x2a;</td>
<td align="left"/>
<td align="left">Levels of TNF-&#x3b1;, IL-1&#x3b2;, IL-8, IF-&#x3b3; and IL-10</td>
<td align="left">
<xref ref-type="bibr" rid="B100">Rodrigues et al. (2020)</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;Indicated this study with cells or tissue from humans.</p>
</fn>
<fn>
<p>ASC, apoptosis-associated speck-like protein; AS, atherosclerosis; DCM, diabetic cardiomyopathy; FGF21, fibroblast growth factor 21; HFD, high-fat diet; HMGB-1, high mobility group box-1; Hcy, homocysteine; HHcy, hyperhomocysteinemia; HF, heart failure; IL, interleukin; &#x3b2;-OHB, &#x3b2;-Hydroxybutyrate; MI, myocardial infarction; NLRP3, NOD-like receptor protein 3; NF-&#x3ba;B, nuclear factor-&#x3ba;B; P2X7, purinergic receptor P2X, ligand-gated ion channel 7; AIN-93G, american institute of nutrition-93 growth).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The investigation of drugs targeting the NLRP3 inflammasome in clinical trials for CVD has been conducted. For example, the canakinumab anti-inflammatory thrombosis outcome study trial demonstrated the efficacy of IL-1-targeting therapy in preventing atherothrombotic events, indicating the potential of targeting the NLRP3 inflammasome (<xref ref-type="bibr" rid="B72">Ma et al., 2021</xref>; <xref ref-type="bibr" rid="B98">Ridker and Rane, 2021</xref>). However, the high cost of canakinumab limits its widespread use in the future. Additionally, long-term suppression of IL-1 signaling may have adverse effects such as increased susceptibility to infections and disturbances in immune homeostasis (<xref ref-type="bibr" rid="B40">Hettwer et al., 2022</xref>). Common cardiovascular drugs such as statins, beta-blockers, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide 1 agonists may modulate NLRP3 inflammasome activity through different mechanisms, exerting protective effects in CVD (<xref ref-type="bibr" rid="B122">Terentes-Printzios et al., 2022</xref>). However, these classical medications carry certain side effects on gastrointestinal function and are prone to causing symptoms like hypotension and arrhythmias (<xref ref-type="bibr" rid="B128">Vaiciuleviciute et al., 2021</xref>). Interestingly, research suggests that exercise effectively modulates NLRP3 inflammasome activation, leading to improvements in AS and other CVD (<xref ref-type="bibr" rid="B128">Vaiciuleviciute et al., 2021</xref>; <xref ref-type="bibr" rid="B122">Terentes-Printzios et al., 2022</xref>). This therapeutic approach is relatively simple, feasible, and considered safe compared to using NLRP3 inhibitors and classical medications for CVD. Therefore, combining medication treatment with exercise intervention offers a potential strategy to improve the quality of life for patients.</p>
</sec>
</body>
<back>
<sec id="s8">
<title>Author contributions</title>
<p>PD: Data curation, Writing&#x2013;original draft, Investigation. YS: Data curation, Writing&#x2013;original draft, Investigation. YY: Investigation, Resources, Supervision, Writing&#x2013;review and editing. CZ: Conceptualization, Funding acquisition, Investigation, Supervision, Visualization, Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (grant number 82100379), Guangzhou Science and Technology Project (grant number 202201010148), Guangdong Provincial Medical Research Fund Project in 2021 (grant number A2021120), Zhuhai People&#x2019;s Hospital Clinical Research Promotion Plan Yucai Project (2023LCTS-42) and National Key Clinical Specialty Construction Project (Clinical Pharmacy) and High-Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmadi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kashef</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rajabi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Salehpour</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effects of exercise preconditioning on NLRP3 and mitochondrial fission in isoproterenol-induced myocardial infarcted rats</article-title>. <source>Comp. Clin. Pathol.</source> <volume>32</volume>, <fpage>289</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1007/s00580-022-03397-3</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alten</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mischkewitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nitschmann</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Febuxostat or allopurinol in patients with gout: cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES)</article-title>. <source>Internist (Berl).</source> <volume>61</volume> (<issue>5</issue>), <fpage>530</fpage>&#x2013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1007/s00108-020-00766-4</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armannia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ghazalian</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shadnoush</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keyvani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gholami</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effects of high-intensity interval vs. moderate-intensity continuous training on body composition and gene expression of ACE2, NLRP3, and FNDC5 in obese adults: a randomized controlled trial</article-title> <source>Med. J. Islam Repub. Iran.</source> <volume>36</volume>, <fpage>161</fpage>. <pub-id pub-id-type="doi">10.47176/mjiri.36.161</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baik</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ramanujan</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fett</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation</article-title>. <source>Sci. Immunol.</source> <volume>8</volume> (<issue>84</issue>), <fpage>eade7652</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.ade7652</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bal</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>Bostanci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sadi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>D&#xf6;nmez</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Uludag</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Demirel</surname>
<given-names>Y. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses</article-title>. <source>Life Sci.</source> <volume>296</volume>, <fpage>120424</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2022.120424</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barr&#xf3;n</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Rosales</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Mora</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez</surname>
<given-names>C. I.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname>
<given-names>L. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Low-grade chronic inflammation is attenuated by exercise training in obese adults through down-regulation of ASC gene in peripheral blood: a pilot study</article-title>. <source>Genes. Nutr.</source> <volume>15</volume>, <fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s12263-020-00674-0</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sandstede</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>K&#xf6;stler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>51</volume> (<issue>19</issue>), <fpage>1883</fpage>&#x2013;<lpage>1891</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2007.09.075</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biguetti</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Cavalla</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Tabanez</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Francisconi</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Taga</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>HGMB1 and RAGE as essential components of ti osseointegration process in mice</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>709</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00709</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanks</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Rodriguez-Miguelez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Looney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Whole body vibration elicits differential immune and metabolic responses in obese and normal weight individuals</article-title>. <source>Brain Behav. Immun. Health</source> <volume>1</volume>, <fpage>100011</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbih.2019.100011</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bockstiegel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weindl</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>P2X7 receptor activation leads to NLRP3-independent IL-1&#x3b2; release by human macrophages</article-title>. <source>Cell. Commun. Signal</source> <volume>21</volume> (<issue>1</issue>), <fpage>335</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-023-01356-1</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boza</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ayala</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vivar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Humeres</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>C&#xe1;ceres</surname>
<given-names>F. T.</given-names>
</name>
<name>
<surname>Mu&#xf1;oz</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1&#x3b2; synthesis, secretion, and degradation</article-title>. <source>Mol. Immunol.</source> <volume>74</volume>, <fpage>96</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2016.05.001</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bracey</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Muruve</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jabagi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1&#x3b2;</article-title>. <source>Exp. Physiol.</source> <volume>98</volume>, <fpage>462</fpage>&#x2013;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.2012.068338</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butts</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dunbar</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Corwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gary</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Effects of exercise on ASC methylation and IL-1 cytokines in heart failure</article-title>. <source>Med. Sci. Sports Exerc</source> <volume>50</volume>, <fpage>1757</fpage>&#x2013;<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000001641</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Junior</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Barreira</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schoenfeld</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Orazem</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Barroso</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Muscle hypertrophy and strength gains after resistance training with different volume-matched loads: a systematic review and meta-analysis</article-title>. <source>Appl. Physiol. Nutr. Metab.</source> <volume>47</volume> (<issue>4</issue>), <fpage>357</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1139/apnm-2021-0515</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casado</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bakken</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tjelta</surname>
<given-names>L. I.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Does lactate-guided threshold interval training within a high-volume low-intensity approach represent the "next step" in the evolution of distance running training?</article-title> <source>Int. J. Environ. Res. Public Health</source> <volume>20</volume> (<issue>5</issue>), <fpage>3782</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph20053782</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Mell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Salt-responsive metabolite, &#x3b2;-hydroxybutyrate, attenuates hypertension</article-title>. <source>Cell. Rep.</source> <volume>25</volume>, <fpage>677</fpage>&#x2013;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.09.058</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Burgener</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Vezyrgiannis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Acklam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Von Pein</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1&#x3b2;-converting enzyme</article-title>. <source>Life Sci. Alliance</source> <volume>6</volume> (<issue>10</issue>), <fpage>e202301908</fpage>. <pub-id pub-id-type="doi">10.26508/lsa.202301908</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Schroder</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inflammasome signaling and regulation of interleukin-1 family cytokines</article-title>. <source>J. Exp. Med.</source> <volume>217</volume>, <fpage>e20190314</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20190314</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>M. X.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Emerging mechanisms and functions of inflammasome complexes in teleost fish</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <fpage>1065181</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1065181</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A pyroptosis nanotuner for cancer therapy</article-title>. <source>Nat. Nanotechnol.</source> <volume>17</volume> (<issue>7</issue>), <fpage>788</fpage>&#x2013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1038/s41565-022-01125-0</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Nylander</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK-mTOR interplay</article-title>. <source>Cardiovasc Drugs Ther.</source> <volume>34</volume> (<issue>4</issue>), <fpage>443</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1007/s10557-020-06978-y</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Loss of Sam50 in hepatocytes induces cardiolipin-dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury</article-title>. <source>Hepatology</source> <volume>76</volume> (<issue>5</issue>), <fpage>1389</fpage>&#x2013;<lpage>1408</lpage>. <pub-id pub-id-type="doi">10.1002/hep.32471</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W. K.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Shibu</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Chang-Lee</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Exercise training augments Sirt1-signaling and attenuates cardiac inflammation in D-galactose induced-aging rats</article-title>. <source>Aging</source> <volume>10</volume>, <fpage>4166</fpage>&#x2013;<lpage>4174</lpage>. <pub-id pub-id-type="doi">10.18632/aging.101714</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Aerobic exercise ameliorates myocardial inflammation, fibrosis and apoptosis in high-fat-diet rats by inhibiting P2X7 purinergic receptors</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <fpage>1286</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.01286</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>NLRP3 inflammasome and IL-1&#x3b2; pathway in type 2 diabetes and atherosclerosis: friend or foe?</article-title> <source>Pharmacol. Res.</source> <volume>173</volume>, <fpage>105885</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105885</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Distinct types of cell death and the implication in diabetic cardiomyopathy</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>42</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00042</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consitt</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Dudley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Impact of endurance and resistance training on skeletal muscle glucose metabolism in older adults</article-title>. <source>Nutrients</source> <volume>11</volume> (<issue>11</issue>), <fpage>2636</fpage>. <pub-id pub-id-type="doi">10.3390/nu11112636</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cutrufello</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Landram</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The effect of music on anaerobic exercise performance and muscular endurance</article-title>. <source>J. Sports Med. Phys. Fit.</source> <volume>60</volume> (<issue>3</issue>), <fpage>486</fpage>&#x2013;<lpage>492</lpage>. <pub-id pub-id-type="doi">10.23736/S0022-4707.19.10228-9</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Pelegr&#xed;n</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Baroja</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cuevas</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Emerging role of the inflammasome and pyroptosis in hypertension</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>1064</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22031064</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deussen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kopaliani</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Targeting inflammation in hypertension</article-title>. <source>Curr. Opin. Nephrol. Hypertens.</source> <volume>32</volume>, <fpage>111</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1097/MNH.0000000000000862</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz-Del-Olmo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Worboys</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martin-Sanchez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gritsenko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ambrose</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Tannahill</surname>
<given-names>G. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Internalization of the membrane attack complex triggers NLRP3 inflammasome activation and IL-1&#x3b2; secretion in human macrophages</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>720655</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.720655</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dilucca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shkarina</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Broz</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Guanylate-binding protein-dependent noncanonical inflammasome activation prevents burkholderia thailandensis-induced multinucleated giant cell formation</article-title>. <source>mBio</source> <volume>12</volume> (<issue>4</issue>), <fpage>e0205421</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.02054-21</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Einarson</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Acs</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Panton</surname>
<given-names>U. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017</article-title>. <source>Cardiovasc Diabetol.</source> <volume>17</volume>, <fpage>83</fpage>. <pub-id pub-id-type="doi">10.1186/s12933-018-0728-6</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Structural mechanisms of NLRP3 inflammasome assembly and activation</article-title>. <source>Annu. Rev. Immunol.</source> <volume>41</volume>, <fpage>301</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-081022-021207</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haidar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Horwich</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Obesity, cardiorespiratory fitness, and cardiovascular disease</article-title>. <source>Curr. Cardiol. Rep.</source> <volume>25</volume> (<issue>11</issue>), <fpage>1565</fpage>&#x2013;<lpage>1571</lpage>. <pub-id pub-id-type="doi">10.1007/s11886-023-01975-7</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Myeloid-specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage</article-title>. <source>Br. J. Pharmacol.</source> <volume>177</volume> (<issue>13</issue>), <fpage>2991</fpage>&#x2013;<lpage>3008</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15026</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassanpour Soleimani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abbassi Daloii</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abdi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zilaei Bori</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Effect of a 6-week aerobic exercise program on high-mobility group box 1 gene expression in aortic tissue of diabetic rats</article-title>. <source>Q. Horizon Med Sci.</source> <volume>27</volume>, <fpage>82</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.32598/hms.27.1.2378.1</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ha&#xdf;</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Heider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kochlik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Herpich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pivovarova-Ramich</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Effects of exercise and omega-3-supplemented, high-protein diet on inflammatory markers in serum, on gene expression levels in PBMC, and after <italic>ex vivo</italic> whole-Blood LPS stimulation in old adults</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>2</issue>), <fpage>928</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24020928</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ha&#xdf;</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kochlik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Herpich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rudloff</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effects of an omega-3 supplemented, high-Protein diet in combination with vibration and resistance exercise on muscle power and inflammation in old adults: a pilot randomized controlled trial</article-title>. <source>Nutrients</source> <volume>14</volume> (<issue>20</issue>), <fpage>4274</fpage>. <pub-id pub-id-type="doi">10.3390/nu14204274</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hettwer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hinterdobler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miritsch</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mauersberger</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Interleukin-1&#x3b2; suppression dampens inflammatory leucocyte production and uptake in atherosclerosis</article-title>. <source>Cardiovasc Res.</source> <volume>118</volume> (<issue>13</issue>), <fpage>2778</fpage>&#x2013;<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvab337</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Markofski</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Marrelli</surname>
<given-names>S. P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Exercise ameliorates endoplasmic reticulum stress-mediated vascular dysfunction in mesenteric arteries in atherosclerosis</article-title>. <source>Sci. Rep.</source> <volume>8</volume> (<issue>1</issue>), <fpage>7938</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-26188-9</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rooney</surname>
<given-names>B. V.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>15449</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-94944-5</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Anas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Endosomal trafficking of two-pore K<sup>&#x2b;</sup> efflux channel TWIK2 to plasmalemma mediates NLRP3 inflammasome activation and inflammatory injury</article-title>. <source>Elife.</source> <volume>12</volume>, <fpage>e83842</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.83842</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javaid</surname>
<given-names>H. M. A.</given-names>
</name>
<name>
<surname>Sahar</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Zhuge</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>J. Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Exercise inhibits NLRP3 inflammasome activation in obese mice via the anti-inflammatory effect of meteorin-like</article-title>. <source>Cells</source> <volume>10</volume>, <fpage>3480</fpage>. <pub-id pub-id-type="doi">10.3390/cells10123480</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Dynamin-related protein 1 is involved in mitochondrial damage, defective mitophagy, and NLRP3 inflammasome activation induced by MSU crystals</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>2022</volume>, <fpage>5064494</fpage>. <pub-id pub-id-type="doi">10.1155/2022/5064494</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shahshahan</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Hackfort</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kambis</surname>
<given-names>T. N.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Exercise training promotes cardiac hydrogen sulfide biosynthesis and mitigates pyroptosis to prevent high-fat diet-induced diabetic cardiomyopathy</article-title>. <source>Antioxidants (Basel)</source> <volume>8</volume>, <fpage>638</fpage>. <pub-id pub-id-type="doi">10.3390/antiox8120638</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khakroo</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Rahmani</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Lombardi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The effects of acute and chronic aerobic activity on the signaling pathway of the inflammasome NLRP3 complex in young men</article-title>. <source>Med. Kaunas.</source> <volume>55</volume>, <fpage>105</fpage>. <pub-id pub-id-type="doi">10.3390/medicina55040105</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sankhe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gopinathan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nandakumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kishore</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation</article-title>. <source>J. Neuroimmune Pharmacol.</source> <volume>19</volume> (<issue>1</issue>), <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1007/s11481-024-10101-5</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ketone metabolite &#x3b2;-hydroxybutyrate ameliorates inflammation after spinal cord injury by inhibiting the NLRP3 inflammasome</article-title>. <source>Neurochem. Res.</source> <volume>46</volume>, <fpage>213</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-020-03156-2</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konishi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yokota</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tokutake</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wakasa</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease</article-title>. <source>Int. J. Cardiol.</source> <volume>49</volume>, <fpage>127</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2021.11.076</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krantz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eklund</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>S&#xe4;rndahl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hedbrant</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>A detailed molecular network map and model of the NLRP3 inflammasome</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <fpage>1233680</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1233680</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-&#x3ba;B and NLRP3 inflammasome activation</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>543</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-80748-6</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Shong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>E. K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes</article-title>. <source>Diabetes</source> <volume>62</volume>, <fpage>194</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.2337/db12-0420</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Umetani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lavoy</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Vascular protection by exercise in obesity: inflammasome-associated mechanisms</article-title>. <source>Med. Sci. Sports Exerc</source> <volume>52</volume>, <fpage>2538</fpage>&#x2013;<lpage>2545</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000002419</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>LaVoy</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Umetani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Physical activity protects NLRP3 inflammasome-associated coronary vascular dysfunction in obese mice</article-title>. <source>Physiol. Rep.</source> <volume>6</volume>, <fpage>e13738</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.13738</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Aiouea padiformis extract exhibits anti-inflammatory effects by inhibiting the ATPase activity of NLRP3</article-title>. <source>Sci. Rep.</source> <volume>14</volume> (<issue>1</issue>), <fpage>5237</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-55651-z</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levine</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Can intensive exercise harm the heart? The benefits of competitive endurance training for cardiovascular structure and function</article-title>. <source>Circulation</source> <volume>130</volume> (<issue>12</issue>), <fpage>987</fpage>&#x2013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.008142</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewisluj&#xe1;n</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>McCarty</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Dinicolantonio</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>G&#xe1;lvezruiz</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Rosas-Burgos</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Plascencia-Jatomea</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Nutraceuticals/drugs promoting mitophagy and mitochondrial biogenesis may combat the mitochondrial dysfunction driving progression of dry age-related macular degeneration</article-title>. <source>Nutrients</source> <volume>14</volume> (<issue>9</issue>), <fpage>1985</fpage>. <pub-id pub-id-type="doi">10.3390/nu14091985</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Exploring exercise-driven inhibition of pyroptosis: novel insights into treating diabetes mellitus and its complications</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>14</volume>, <fpage>1230646</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2023.1230646</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Q. N.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Aerobic exercise regulates FGF21 and NLRP3 inflammasome-mediated pyroptosis and inhibits atherosclerosis in mice</article-title>. <source>PLoS One</source> <volume>17</volume>, <fpage>e0273527</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0273527</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Different intensity exercise preconditions affect cardiac function of exhausted rats through regulating TXNIP/TRX/NF-&#x138;Bp65/NLRP3 inflammatory pathways</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2020</volume>, <fpage>5809298</fpage>. <pub-id pub-id-type="doi">10.1155/2020/5809298</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>Y. T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Plasma proteomic changes of atherosclerosis after exercise in apoE knockout mice</article-title>. <source>Biol. (Basel).</source> <volume>11</volume> (<issue>2</issue>), <fpage>253</fpage>. <pub-id pub-id-type="doi">10.3390/biology11020253</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Immune adaptation to chronic intense exercise training: new microarray evidence</article-title>. <source>BMC Genom</source> <volume>18</volume>, <fpage>29</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-016-3388-5</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Piao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-&#x3ba;B and NLRP3/caspase-1/GSDMD signaling</article-title>. <source>Biomed. Pharmacother.</source> <volume>158</volume>, <fpage>114118</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.114118</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>HHcy induces pyroptosis and atherosclerosis via the lipid raft-mediated NOX-ROS-NLRP3 inflammasome pathway in apoE-/- mice</article-title>. <source>Cells</source> <volume>11</volume>, <fpage>2438</fpage>. <pub-id pub-id-type="doi">10.3390/cells11152438</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Mitochondrial DNA induces nucleus pulposus cell pyroptosis via the TLR9-NF-&#x3ba;B-NLRP3 axis</article-title>. <source>J. Transl. Med.</source> <volume>21</volume> (<issue>1</issue>), <fpage>389</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-023-04266-5</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Qiliqiangxin modulates the gut microbiota and NLRP3 inflammasome to protect against ventricular remodeling in heart failure</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>905424</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.905424</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy</article-title>. <source>Front. Physiol.</source> <volume>8</volume>, <fpage>519</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00519</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e104771</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0104771</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Niebauer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Effects of different intensities of continuous training on vascular inflammation and oxidative stress in spontaneously hypertensive rats</article-title>. <source>J. Cell. Mol. Med.</source> <volume>25</volume>, <fpage>8522</fpage>&#x2013;<lpage>8536</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.16813</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Anti-inflammatory therapy for coronary atherosclerotic heart disease: unanswered questions behind existing successes</article-title>. <source>Front. Cardiovasc Med.</source> <volume>7</volume>, <fpage>631398</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2020.631398</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Aerobic exercise ameliorates cardiac hypertrophy by regulating mitochondrial quality control and endoplasmic reticulum stress through M2 AChR</article-title>. <source>J. Cell. Physiol.</source> <volume>236</volume>, <fpage>6581</fpage>&#x2013;<lpage>6596</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.30342</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mardare</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kruger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liebisch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Seimetz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Couturier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ringseis</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Endurance and resistance training affect high fat diet-induced increase of ceramides, inflammasome expression, and systemic inflammation in mice</article-title>. <source>J. Diabetes. Res.</source> <volume>2016</volume>, <fpage>4536470</fpage>. <pub-id pub-id-type="doi">10.1155/2016/4536470</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mason</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Trewin</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wadley</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antioxidant supplements and endurance exercise: current evidence and mechanistic insights</article-title>. <source>Redox. Biol.</source> <volume>35</volume>, <fpage>101471</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2020.101471</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Treadwell</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Increasing exercise intensity: teaching high-intensity interval training to individuals with developmental disabilities using a lottery reinforcement system</article-title>. <source>Behav. Anal. Pract.</source> <volume>13</volume> (<issue>4</issue>), <fpage>826</fpage>&#x2013;<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1007/s40617-020-00428-9</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCullough</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Coronary artery plaque and cardiotoxicity as a result of extreme endurance exercise</article-title>. <source>Mo Med.</source> <volume>111</volume> (<issue>2</issue>), <fpage>95</fpage>&#x2013;<lpage>98</lpage>.</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKee</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Coll</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma</article-title>. <source>J. Leukoc. Biol.</source> <volume>108</volume>, <fpage>937</fpage>&#x2013;<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1002/JLB.3MR0720-513R</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Memme</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Erlich</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Phukan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Exercise and mitochondrial health</article-title>. <source>J. Physiol.</source> <volume>2021</volume>, <fpage>803</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1113/JP278853</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mensah</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Fuster</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The global burden of cardiovascular diseases and risk factors: 2020 and beyond</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>74</volume> (<issue>20</issue>), <fpage>2529</fpage>&#x2013;<lpage>2532</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2019.10.009</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mezzaroma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toldo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seropian</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Van Tassell</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Salloum</surname>
<given-names>F. N.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>108</volume>, <fpage>19725</fpage>&#x2013;<lpage>19730</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1108586108</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miko</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Zillmann</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ring-Dimitriou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dorner</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Effects of physical activity on health</article-title>. <source>Gesundheitswesen</source> <volume>82</volume> (<issue>S 03</issue>), <fpage>S184-S195</fpage>&#x2013;<lpage>S195</lpage>. <pub-id pub-id-type="doi">10.1055/a-1217-0549</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Movahedpour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taghvaeefar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Asadi-Pooya</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Karami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tavasolian</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Khatami</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Nano-delivery systems as a promising therapeutic potential for epilepsy: current status and future perspectives</article-title>. <source>CNS Neurosci. Ther.</source> <volume>29</volume> (<issue>11</issue>), <fpage>3150</fpage>&#x2013;<lpage>3159</lpage>. <pub-id pub-id-type="doi">10.1111/cns.14355</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Winzer</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Duvinage</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gevaert</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Edelmann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: a randomized clinical trial</article-title>. <source>Jama</source> <volume>325</volume>, <fpage>542</fpage>&#x2013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.26812</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>K. O.</given-names>
</name>
<name>
<surname>Mahoney</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Venkatasubramanian</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seals</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>Z. S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Aging, aerobic exercise, and cardiovascular health: barriers, alternative strategies and future directions</article-title>. <source>Exp. Gerontol.</source> <volume>173</volume>, <fpage>112105</fpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2023.112105</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napodano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carnazzo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pocino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stefanile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gallucci</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>NLRP3 inflammasome involvement in heart, liver, and lung diseases-a lesson from cytokine storm syndrome</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>23</issue>), <fpage>16556</fpage>. <pub-id pub-id-type="doi">10.3390/ijms242316556</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nath</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>La Gerche</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Forbes</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Associations between postrace atrial fibrillation and measures of performance, racing history and airway disease in horses</article-title>. <source>J. Vet. Intern Med.</source> <volume>37</volume> (<issue>6</issue>), <fpage>2573</fpage>&#x2013;<lpage>2583</lpage>. <pub-id pub-id-type="doi">10.1111/jvim.16878</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuman</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Albright</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Schalinske</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Exercise prevents hyperhomocysteinemia in a dietary folate-restricted mouse model</article-title>. <source>Nutr. Res.</source> <volume>33</volume>, <fpage>487</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutres.2013.04.008</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Jagemann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Makarova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>B&#xf6;rschel</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Aarabi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gutmann</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mediterranean diet and atrial fibrillation: lessons learned from the AFHRI case-control study</article-title>. <source>Nutrients</source> <volume>14</volume> (<issue>17</issue>), <fpage>3615</fpage>. <pub-id pub-id-type="doi">10.3390/nu14173615</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Verdin</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>&#x3b2;-hydroxybutyrate: much more than a metabolite</article-title>. <source>Diabetes Res. Clin. Pract.</source> <volume>106</volume>, <fpage>173</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.diabres.2014.08.009</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Regulated cell death in urinary malignancies</article-title>. <source>Front. Cell. Dev. Biol.</source> <volume>9</volume>, <fpage>789004</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.789004</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Keefe</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Sturgess</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>O&#x27;Keefe</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Prevention and treatment of atrial fibrillation via risk factor modification</article-title>. <source>Am. J. Cardiol.</source> <volume>160</volume>, <fpage>46</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2021.08.042</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Keefe</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Magalski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>McCullough</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Potential adverse cardiovascular effects from excessive endurance exercise</article-title>. <source>Mayo Clin. Proc.</source> <volume>87</volume> (<issue>6</issue>), <fpage>587</fpage>&#x2013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2012.04.005</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paerewijck</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lamkanfi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The human inflammasomes</article-title>. <source>Mol. Asp. Med.</source> <volume>88</volume>, <fpage>101100</fpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2022.101100</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paluch</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Laddu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lobelo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D. C.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Resistance exercise training in individuals with and without cardiovascular disease: 2023 update: a scientific statement from the American heart association</article-title>. <source>Circulation</source> <volume>149</volume> (<issue>3</issue>), <fpage>e217</fpage>&#x2013;<lpage>e231</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000001189</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pope</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease</article-title>. <source>Neurosci. Biobehav Rev.</source> <volume>116</volume>, <fpage>337</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.06.031</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Deminice</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ozdemir</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bomkamp</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Hyatt</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Exercise-induced oxidative stress: friend or foe?</article-title> <source>J. Sport Health Sci.</source> <volume>9</volume>, <fpage>415</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/j.jshs.2020.04.001</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination</article-title>. <source>EMBO J.</source> <volume>38</volume> (<issue>6</issue>), <fpage>e100376</fpage>. <pub-id pub-id-type="doi">10.15252/embj.2018100376</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridker</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Rane</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease</article-title>. <source>Circ. Res.</source> <volume>128</volume> (<issue>11</issue>), <fpage>1728</fpage>&#x2013;<lpage>1746</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.319077</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ringseis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eder</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mooren</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Metabolic signals and innate immune activation in obesity and exercise</article-title>. <source>Exerc Immunol. Rev.</source> <volume>21</volume>, <fpage>58</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1111/jpn.12263</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues Junior</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>F. S. N. S.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>V. L. M.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Sperandio da Silva</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>R. O.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe chagas cardiomyopathy: a pilot single-arm clinical trial</article-title>. <source>J. Res. Med. Sci.</source> <volume>25</volume>, <fpage>18</fpage>. <pub-id pub-id-type="doi">10.4103/jrms.JRMS_175_18</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roncero-Ramos</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rangel-Zu&#xf1;iga</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Lopez-Moreno</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alcala-Diaz</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Perez-Martinez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jimenez-Lucena</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Mediterranean diet, glucose homeostasis, and inflammasome genetic variants: the CORDIOPREV study</article-title>. <source>Mol. Nutr. Food Res.</source> <volume>62</volume> (<issue>9</issue>), <fpage>e1700960</fpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201700960</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothschild</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Effects of dietary supplements on adaptations to endurance training</article-title>. <source>Sports Med.</source> <volume>50</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-019-01185-8</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Structural insight of gasdermin family driving pyroptotic cell death</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>1172</volume>, <fpage>189</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-9367-9_9</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacco</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Bliss</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Living with heart failure: psychosocial resources, meaning, gratitude and well-being</article-title>. <source>Heart Lung</source> <volume>43</volume>, <fpage>213</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrtlng.2014.01.012</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salo</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Donovan</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>HSP70 and other possible heat shock or oxidative stress proteins are induced in skeletal muscle, heart, and liver during exercise</article-title>. <source>Free Radic. Biol. Med.</source> <volume>11</volume>, <fpage>239</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(91)90119-N</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandall</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Effects of phosphorylation on the NLRP3 inflammasome</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>670</volume>, <fpage>43</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2019.02.020</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandanger</surname>
<given-names>&#xd8;.</given-names>
</name>
<name>
<surname>Ranheim</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vinge</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Bliks&#xf8;en</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alfsnes</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Finsen</surname>
<given-names>A. V.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury</article-title>. <source>Cardiovasc Res.</source> <volume>99</volume>, <fpage>164</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvt091</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoenfeld</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Ogborn</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Effects of resistance training frequency on measures of muscle hypertrophy: a systematic review and meta-analysis</article-title>. <source>Sports Med.</source> <volume>46</volume> (<issue>11</issue>), <fpage>1689</fpage>&#x2013;<lpage>1697</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-016-0543-8</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Wickstrom</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Peichel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Garberich</surname>
<given-names>R. F.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Increased coronary artery plaque volume among male marathon runners</article-title>. <source>Mo Med.</source> <volume>111</volume> (<issue>2</issue>), <fpage>89</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.paid.2014.03.024</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spalding</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Arner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Westermark</surname>
<given-names>P. O.</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buchholz</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Dynamics of fat cell turnover in humans</article-title>. <source>Nature</source> <volume>453</volume>, <fpage>783</fpage>&#x2013;<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1038/nature06902</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spalinger</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gottier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Atrott</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vavricka</surname>
<given-names>S. R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22</article-title>. <source>J. Clin. Investig.</source> <volume>133</volume> (<issue>4</issue>), <fpage>e169304</fpage>. <pub-id pub-id-type="doi">10.1172/JCI169304</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spalinger</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Schwarzfischer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scharl</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The role of Protein tyrosine phosphatases in inflammasome activation</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>15</issue>), <fpage>5481</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21155481</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stensvold</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sl&#xf8;rdahl</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Wisl&#xf8;ff</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Effect of exercise training on inflammation status among people with metabolic syndrome</article-title>. <source>Metab. Syndr. Relat. Disord.</source> <volume>10</volume>, <fpage>267</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1089/met.2011.0140</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stienstra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Diepen</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Tack</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>G. A.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Inflammasome is a central player in the induction of obesity and insulin resistance</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>108</volume>, <fpage>15324</fpage>&#x2013;<lpage>15329</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1100255108</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolen</surname>
<given-names>K. Q.</given-names>
</name>
<name>
<surname>Kemppainen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ukkonen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kalliokoski</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Luotolahti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lehikoinen</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>41</volume> (<issue>3</issue>), <fpage>460</fpage>&#x2013;<lpage>467</lpage>. <pub-id pub-id-type="doi">10.1016/s0735-1097(02)02772-9</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stumvoll</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>van Haeften</surname>
<given-names>T. W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Type 2 diabetes: principles of pathogenesis and therapy</article-title>. <source>Lancet</source> <volume>365</volume>, <fpage>1333</fpage>&#x2013;<lpage>1346</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)61032-X</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Protective role and molecular mechanism of action of nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells</article-title>. <source>Exp. Ther. Med.</source> <volume>22</volume>, <fpage>833</fpage>. <pub-id pub-id-type="doi">10.3892/etm.2021.10265</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X. S.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension</article-title>. <source>Cell. Death Dis.</source> <volume>8</volume>, <fpage>e3074</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2017.470</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>NLRP3 inflammasome in diabetic cardiomyopathy and exercise intervention</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>13228</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222413228</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>K. V.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The NLRP3 inflammasome: molecular activation and regulation to therapeutics</article-title>. <source>Nat. Rev. Immunol.</source> <volume>19</volume> (<issue>8</issue>), <fpage>477</fpage>&#x2013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0165-0</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cell-specific roles of NLRP3 inflammasome in myocardial infarction</article-title>. <source>J. Cardiovasc Pharmacol.</source> <volume>74</volume> (<issue>3</issue>), <fpage>188</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1097/FJC.0000000000000709</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terentes-Printzios</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ioakeimidis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rokkas</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vlachopoulos</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>19</volume> (<issue>1</issue>), <fpage>59</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-021-00593-6</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>van Rij</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Repeated episodes of remote ischemic preconditioning for the prevention of myocardial injury in vascular surgery</article-title>. <source>Vasc. Endovasc. Surg.</source> <volume>50</volume> (<issue>3</issue>), <fpage>140</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1177/1538574416639150</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troosters</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Demeyer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rabinovich</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Pulmonary rehabilitation and physical interventions</article-title>. <source>Eur. Respir. Rev.</source> <volume>32</volume> (<issue>168</issue>), <fpage>220222</fpage>. <pub-id pub-id-type="doi">10.1183/16000617.0222-2022</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tr&#xf8;seid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lappeg&#xe5;rd</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Mollnes</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Arnesen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seljeflot</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome</article-title>. <source>Metab. Syndr. Relat. Disord.</source> <volume>7</volume>, <fpage>579</fpage>&#x2013;<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1089/met.2009.0003</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Fegers-Wustrow</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Halle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haykowsky</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Kovacic</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Exercise for primary and secondary prevention of cardiovascular disease: jacc focus seminar 1/4</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>80</volume>, <fpage>1091</fpage>&#x2013;<lpage>1106</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2022.07.004</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tutor</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Kachur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Milani</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>H. O.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Updates on obesity and the obesity paradox in cardiovascular diseases</article-title>. <source>Prog. Cardiovasc Dis.</source> <volume>78</volume>, <fpage>2</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2022.11.013</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaiciuleviciute</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bironaite</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Uzieliene</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mobasheri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bernotiene</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cardiovascular drugs and osteoarthritis: effects of targeting ion channels</article-title>. <source>Cells</source> <volume>10</volume> (<issue>10</issue>), <fpage>2572</fpage>. <pub-id pub-id-type="doi">10.3390/cells10102572</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valenzuela</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Ruilope</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Santos-Lozano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kr&#xe4;nkel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fiuza-Luces</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation</article-title>. <source>Eur. Heart J.</source> <volume>44</volume> (<issue>21</issue>), <fpage>1874</fpage>&#x2013;<lpage>1889</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehad170</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandanmagsar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Youm</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Ravussin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Galgani</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Stadler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mynatt</surname>
<given-names>R. L.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance</article-title>. <source>Nat. Med.</source> <volume>17</volume>, <fpage>179</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2279</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veeranki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tyagi</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Defective homocysteine metabolism: potential implications for skeletal muscle malfunction</article-title>. <source>Int. J. Mol. Sci.</source> <volume>14</volume>, <fpage>15074</fpage>&#x2013;<lpage>15091</lpage>. <pub-id pub-id-type="doi">10.3390/ijms140715074</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vella</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Drummer</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>High-intensity interval and moderate-intensity continuous training elicit similar enjoyment and adherence levels in overweight and obese adults</article-title>. <source>Eur. J. Sport Sci.</source> <volume>17</volume> (<issue>9</issue>), <fpage>1203</fpage>&#x2013;<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1080/17461391.2017.1359679</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Bourguignon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults</article-title>. <source>Obes. (Silver Spring)</source> <volume>14</volume>, <fpage>1921</fpage>&#x2013;<lpage>1930</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2006.224</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aruga</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance</article-title>. <source>J. Endocrinol.</source> <volume>235</volume> (<issue>3</issue>), <fpage>179</fpage>&#x2013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1530/JOE-17-0351</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of high-intensity interval training on cardiac structure and function in rats with acute myocardial infarct</article-title>. <source>Biomed. Pharmacother.</source> <volume>131</volume>, <fpage>110690</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110690</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Aerobic exercise improves synaptic-related proteins of diabetic rats by inhibiting FOXO1/NF-&#x3ba;B/NLRP3 inflammatory signaling pathway and ameliorating PI3K/Akt insulin signaling pathway</article-title>. <source>J. Mol. Neurosci.</source> <volume>69</volume> (<issue>1</issue>), <fpage>28</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-019-01302-2</pub-id>
</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice</article-title>. <source>Lab. Investig.</source> <volume>97</volume>, <fpage>922</fpage>&#x2013;<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2017.30</pub-id>
</citation>
</ref>
<ref id="B138">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Aerobic exercise inhibited P2X7 purinergic receptors to improve cardiac remodeling in mice with type 2 diabetes</article-title>. <source>Front. Physiol.</source> <volume>13</volume>, <fpage>828020</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2022.828020</pub-id>
</citation>
</ref>
<ref id="B139">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Usui-Kawanishi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Karasawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kamata</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Komada</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages</article-title>. <source>J. Cell. Physiol.</source> <volume>235</volume> (<issue>10</issue>), <fpage>7554</fpage>&#x2013;<lpage>7566</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.29659</pub-id>
</citation>
</ref>
<ref id="B140">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winchester</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Veeranki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Givvimani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tyagi</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes</article-title>. <source>Can. J. Physiol. Pharmacol.</source> <volume>92</volume>, <fpage>575</fpage>&#x2013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2014-0059</pub-id>
</citation>
</ref>
<ref id="B141">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Sattar</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>20</volume> (<issue>10</issue>), <fpage>685</fpage>&#x2013;<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-023-00877-z</pub-id>
</citation>
</ref>
<ref id="B142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The effect of high glucose-based peritoneal dialysis fluids on thioredoxin-interacting protein expression in human peritoneal mesothelial cells</article-title>. <source>Int. Immunopharmacol.</source> <volume>66</volume>, <fpage>198</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2018.11.027</pub-id>
</citation>
</ref>
<ref id="B143">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Caspase-4/11-mediated pulmonary artery endothelial cell pyroptosis contributes to pulmonary arterial hypertension</article-title>. <source>Hypertension</source> <volume>79</volume>, <fpage>536</fpage>&#x2013;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.121.17868</pub-id>
</citation>
</ref>
<ref id="B144">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>TXNIP regulates NLRP3 inflammasome-induced pyroptosis related to aging via cAMP/PKA and PI3K/Akt signaling pathways</article-title>. <source>Mol. Neurobiol.</source> <pub-id pub-id-type="doi">10.1007/s12035-024-04089-5</pub-id>
</citation>
</ref>
<ref id="B145">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watari</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sanchez-Lopez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Offenberger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Onyuru</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sampath</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling</article-title>. <source>Immunity</source> <volume>55</volume> (<issue>8</issue>), <fpage>1370</fpage>&#x2013;<lpage>1385.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2022.06.007</pub-id>
</citation>
</ref>
<ref id="B146">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Chemerin/cmklr1 axis promotes inflammation and pyroptosis by activating NLRP3 inflammasome in diabetic cardiomyopathy rat</article-title>. <source>Front. Physiol.</source> <volume>11</volume>, <fpage>381</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2020.00381</pub-id>
</citation>
</ref>
<ref id="B147">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Irisin inhibits NLRP3 inflammasome activation in HG/HF incubated cardiac microvascular endothelial cells with H/R injury</article-title>. <source>Microcirculation</source> <volume>29</volume> (<issue>8</issue>), <fpage>e12786</fpage>. <pub-id pub-id-type="doi">10.1111/micc.12786</pub-id>
</citation>
</ref>
<ref id="B148">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Exercise improves the function of endothelial cells by microrna</article-title>. <source>J. Cardiovasc Transl. Res.</source> <volume>12</volume>, <fpage>391</fpage>&#x2013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1007/s12265-018-9855-4</pub-id>
</citation>
</ref>
<ref id="B149">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Exercise mitigates endothelial pyroptosis and atherosclerosis by downregulating NEAT1 through N6-methyladenosine modifications</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source> <volume>43</volume>, <fpage>910</fpage>&#x2013;<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.123.319251</pub-id>
</citation>
</ref>
<ref id="B150">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Z. Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Inhibition of AIM2 inflammasome activation alleviates GSDMD-induced pyroptosis in early brain injury after subarachnoid haemorrhage</article-title>. <source>Cell. Death Dis.</source> <volume>11</volume> (<issue>1</issue>), <fpage>76</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-2248-z</pub-id>
</citation>
</ref>
<ref id="B151">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy</article-title>. <source>Redox Biol.</source> <volume>34</volume>, <fpage>101523</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2020.101523</pub-id>
</citation>
</ref>
<ref id="B152">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Role of pyroptosis in cardiovascular diseases and its therapeutic implications</article-title>. <source>Int. J. Biol. Sci.</source> <volume>15</volume>, <fpage>1345</fpage>&#x2013;<lpage>1357</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.33568</pub-id>
</citation>
</ref>
<ref id="B153">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis</article-title>. <source>Exp. Cell. Res.</source> <volume>393</volume> (<issue>2</issue>), <fpage>112108</fpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2020.112108</pub-id>
</citation>
</ref>
<ref id="B154">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Adiponectin alleviates nlrp3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting foxo4 in arteriosclerosis</article-title>. <source>Biochem. Biophys. Res.</source> <volume>514</volume>, <fpage>266</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.04.143</pub-id>
</citation>
</ref>
<ref id="B155">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Naji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Bisphosphonate induces osteonecrosis of the jaw in diabetic mice via NLRP3/caspase-1-dependent IL-1&#x3b2; mechanism</article-title>. <source>J. Bone Min. Res.</source> <volume>30</volume>, <fpage>2300</fpage>&#x2013;<lpage>2312</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.2577</pub-id>
</citation>
</ref>
<ref id="B156">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Research progress of mitochondrial mechanism in NLRP3 inflammasome activation and exercise regulation of NLRP3 inflammasome</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>19</issue>), <fpage>10866</fpage>. <pub-id pub-id-type="doi">10.3390/ijms221910866</pub-id>
</citation>
</ref>
<ref id="B157">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis</article-title>. <source>Exp. Mol. Med.</source> <volume>54</volume> (<issue>2</issue>), <fpage>129</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1038/s12276-022-00729-9</pub-id>
</citation>
</ref>
<ref id="B158">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kvietys</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C. M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e107639</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0107639</pub-id>
</citation>
</ref>
<ref id="B159">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondrial ROS-induced TXNIP upregulation contributes to NLRP3 inflammasome activation in diabetic cardiomyopathy</article-title>. <source>Redox Biol.</source> <volume>44</volume>, <fpage>101913</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2021.101913</pub-id>
</citation>
</ref>
<ref id="B160">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Recent advances in the NEK7-licensed NLRP3 inflammasome activation: mechanisms, role in diseases and related inhibitors</article-title>. <source>J. Autoimmun.</source> <volume>113</volume>, <fpage>102515</fpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2020.102515</pub-id>
</citation>
</ref>
<ref id="B161">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhaolin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiaojiao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yami</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tingting</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway</article-title>. <source>J. Cell. Physiol.</source> <volume>234</volume>, <fpage>7475</fpage>&#x2013;<lpage>7491</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27509</pub-id>
</citation>
</ref>
<ref id="B162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Structural mechanisms for regulation of GSDMB pore-forming activity</article-title>. <source>Nature</source> <volume>616</volume> (<issue>7957</issue>), <fpage>598</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-023-05872-5</pub-id>
</citation>
</ref>
<ref id="B163">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tardive</surname>
<given-names>l A.</given-names>
</name>
<name>
<surname>Thorens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tschopp</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Thioredoxin-interacting protein links oxidative stress to inflammasome activation</article-title>. <source>Nat. Immunol.</source> <volume>11</volume>, <fpage>136</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1831</pub-id>
</citation>
</ref>
<ref id="B164">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The roles of endoplasmic reticulum in NLRP3 inflammasome activation</article-title>. <source>Cells</source> <volume>9</volume> (<issue>5</issue>), <fpage>1219</fpage>. <pub-id pub-id-type="doi">10.3390/cells9051219</pub-id>
</citation>
</ref>
<ref id="B165">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation</article-title>. <source>Exp. Gerontol.</source> <volume>168</volume>, <fpage>111934</fpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2022.111934</pub-id>
</citation>
</ref>
</ref-list>
<sec id="s12">
<title>Glossary</title>
<table-wrap id="udT1" position="float">
<table>
<tbody valign="top">
<tr>
<td align="left">
<bold>ASC</bold>
</td>
<td align="left">apoptosis-associated speck-like protein</td>
</tr>
<tr>
<td align="left">
<bold>AS</bold>
</td>
<td align="left">atherosclerosis</td>
</tr>
<tr>
<td align="left">
<bold>AT</bold>
</td>
<td align="left">adipose tissue</td>
</tr>
<tr>
<td align="left">
<bold>BMDM</bold>
</td>
<td align="left">bone marrow-derived macrophages</td>
</tr>
<tr>
<td align="left">
<bold>BP</bold>
</td>
<td align="left">blood pressure</td>
</tr>
<tr>
<td align="left">
<bold>CVD</bold>
</td>
<td align="left">cardiovascular diseases</td>
</tr>
<tr>
<td align="left">
<bold>CARD</bold>
</td>
<td align="left">caspase recruitment domain</td>
</tr>
<tr>
<td align="left">
<bold>DAMPs</bold>
</td>
<td align="left">damage-associated molecular patterns</td>
</tr>
<tr>
<td align="left">
<bold>DCM</bold>
</td>
<td align="left">diabetic cardiomyopathy</td>
</tr>
<tr>
<td align="left">
<bold>Drp1</bold>
</td>
<td align="left">dynamin-related protein 1</td>
</tr>
<tr>
<td align="left">
<bold>ET</bold>
</td>
<td align="left">endurance training</td>
</tr>
<tr>
<td align="left">
<bold>EP</bold>
</td>
<td align="left">exercise preconditioning</td>
</tr>
<tr>
<td align="left">
<bold>EE</bold>
</td>
<td align="left">exhaustive exercise</td>
</tr>
<tr>
<td align="left">
<bold>EEE</bold>
</td>
<td align="left">excessive endurance exercise</td>
</tr>
<tr>
<td align="left">
<bold>FGF21</bold>
</td>
<td align="left">fibroblast growth factor 21</td>
</tr>
<tr>
<td align="left">
<bold>FOXO1</bold>
</td>
<td align="left">forkhead box transcription factor O1</td>
</tr>
<tr>
<td align="left">
<bold>GSDMD</bold>
</td>
<td align="left">gasdermin D</td>
</tr>
<tr>
<td align="left">
<bold>NT</bold>
</td>
<td align="left">n-terminal</td>
</tr>
<tr>
<td align="left">
<bold>NOX4</bold>
</td>
<td align="left">nicotinamide adenine dinucleotide phosphate oxidase 4</td>
</tr>
<tr>
<td align="left">
<bold>HFD</bold>
</td>
<td align="left">high-fat diet</td>
</tr>
<tr>
<td align="left">
<bold>HMGB-1</bold>
</td>
<td align="left">high mobility group box-1</td>
</tr>
<tr>
<td align="left">
<bold>Hcy</bold>
</td>
<td align="left">homocysteine</td>
</tr>
<tr>
<td align="left">
<bold>HHcy</bold>
</td>
<td align="left">hyperhomocysteinemia</td>
</tr>
<tr>
<td align="left">
<bold>HIIT</bold>
</td>
<td align="left">high-intensity interval training</td>
</tr>
<tr>
<td align="left">
<bold>HF</bold>
</td>
<td align="left">heart failure</td>
</tr>
<tr>
<td align="left">
<bold>IL</bold>
</td>
<td align="left">interleukin</td>
</tr>
<tr>
<td align="left">
<bold>LRR</bold>
</td>
<td align="left">leucine-rich repeat</td>
</tr>
<tr>
<td align="left">
<bold>LICT</bold>
</td>
<td align="left">low-intensity continuous training</td>
</tr>
<tr>
<td align="left">
<bold>IR</bold>
</td>
<td align="left">insulin resistance</td>
</tr>
<tr>
<td align="left">
<bold>LPS</bold>
</td>
<td align="left">lipopolysaccharide</td>
</tr>
<tr>
<td align="left">
<bold>&#x3b2;-OHB</bold>
</td>
<td align="left">&#x3b2;-Hydroxybutyrate</td>
</tr>
<tr>
<td align="left">
<bold>MICT</bold>
</td>
<td align="left">moderate-intensity continuous training</td>
</tr>
<tr>
<td align="left">
<bold>MI</bold>
</td>
<td align="left">myocardial infarction</td>
</tr>
<tr>
<td align="left">
<bold>mtROS</bold>
</td>
<td align="left">mitochondrial ROS</td>
</tr>
<tr>
<td align="left">
<bold>HR</bold>
<sub>
<bold>max</bold>
</sub>
</td>
<td align="left">maximum heart rate</td>
</tr>
<tr>
<td align="left">
<bold>VO</bold>
<sub>
<bold>2max</bold>
</sub>
</td>
<td align="left">maximum volume of oxygen</td>
</tr>
<tr>
<td align="left">
<bold>NLRP3</bold>
</td>
<td align="left">NOD-like receptor protein 3</td>
</tr>
<tr>
<td align="left">
<bold>NLR</bold>
</td>
<td align="left">nucleotide-binding domain-like receptor</td>
</tr>
<tr>
<td align="left">
<bold>NF-&#x3ba;B</bold>
</td>
<td align="left">nuclear factor-&#x3ba;B</td>
</tr>
<tr>
<td align="left">
<bold>NEAT1</bold>
</td>
<td align="left">nuclear paraspeckle assembly transcript 1</td>
</tr>
<tr>
<td align="left">
<bold>PAMPs</bold>
</td>
<td align="left">pathogen-associated molecular patterns</td>
</tr>
<tr>
<td align="left">
<bold>PYD</bold>
</td>
<td align="left">pyrin domain</td>
</tr>
<tr>
<td align="left">
<bold>P2X7</bold>
</td>
<td align="left">purinergic receptor P2X, ligand-gated ion channel 7</td>
</tr>
<tr>
<td align="left">
<bold>ROS</bold>
</td>
<td align="left">reactive oxygen species</td>
</tr>
<tr>
<td align="left">
<bold>RT</bold>
</td>
<td align="left">resistance training</td>
</tr>
<tr>
<td align="left">
<bold>SHR</bold>
</td>
<td align="left">spontaneously hypertensive rats</td>
</tr>
<tr>
<td align="left">
<bold>TGN</bold>
</td>
<td align="left">trans-golgi network</td>
</tr>
<tr>
<td align="left">
<bold>TXNIP</bold>
</td>
<td align="left">thioredoxin interacting protein</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</back>
</article>